Cover
Cover - shares | 3 Months Ended | |
Mar. 31, 2023 | May 09, 2023 | |
Cover [Abstract] | ||
Document Type | 10-Q | |
Document Quarterly Report | true | |
Document Period End Date | Mar. 31, 2023 | |
Document Transition Report | false | |
Entity File Number | 001-40495 | |
Entity Registrant Name | Angel Oak Mortgage REIT, Inc. | |
Entity Incorporation, State or Country Code | MD | |
Entity Tax Identification Number | 37-1892154 | |
Entity Address, Address Line One | 3344 Peachtree Road Northeast | |
Entity Address, Address Line Two | Suite 1725 | |
Entity Address, City or Town | Atlanta | |
Entity Address, State or Province | GA | |
Entity Address, Postal Zip Code | 30326 | |
City Area Code | 404 | |
Local Phone Number | 953-4900 | |
Title of 12(b) Security | Common stock, $0.01 par value | |
Trading Symbol | AOMR | |
Security Exchange Name | NYSE | |
Entity Current Reporting Status | Yes | |
Entity Interactive Data Current | Yes | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Common Stock, Shares Outstanding | 24,879,303 | |
Entity Central Index Key | 0001766478 | |
Amendment Flag | false | |
Document Fiscal Period Focus | Q1 | |
Document Fiscal Year Focus | 2023 | |
Current Fiscal Year End Date | --12-31 |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
ASSETS | ||
Cash and cash equivalents | $ 36,772 | $ 29,272 |
Restricted cash | 20,845 | 10,589 |
Principal and interest receivable | 13,645 | 17,497 |
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 0 | 14,756 |
Other assets | 16,244 | 4,767 |
Total assets | 2,599,169 | 2,946,212 |
LIABILITIES | ||
Notes payable | 439,252 | 639,870 |
Securities sold under agreements to repurchase | 442,214 | 52,544 |
Due to broker | 447,568 | 1,006,022 |
Unrealized depreciation on TBAs and interest rate futures contracts - at fair value | 8,417 | 0 |
Accrued expenses | 652 | 1,288 |
Accrued expenses payable to affiliate | 1,184 | 2,006 |
Interest payable | 1,281 | 2,551 |
Management fee payable to affiliate | 1,519 | 1,967 |
Total liabilities | 2,354,791 | 2,709,733 |
Commitments and contingencies | ||
STOCKHOLDERS’ EQUITY | ||
Common stock, $0.01 par value. As of March 31, 2023: 350,000,000 shares authorized, 24,925,357 shares issued and outstanding. As of December 31, 2022: 350,000,000 shares authorized, 24,925,357 shares issued and outstanding. | 249 | 249 |
Additional paid-in capital | 475,920 | 475,379 |
Accumulated other comprehensive loss | (6,323) | (21,127) |
Retained deficit | (225,468) | (218,022) |
Total stockholders’ equity | 244,378 | 236,479 |
Total liabilities and stockholders’ equity | 2,599,169 | 2,946,212 |
Non-recourse | ||
LIABILITIES | ||
Non-recourse securitization obligation, collateralized by residential mortgage loans in securitization trusts (see Note 2) | 1,012,704 | 1,003,485 |
RMBS | ||
ASSETS | ||
Debt securities, available-for-sale | 522,887 | 1,055,338 |
LIABILITIES | ||
Securities sold under agreements to repurchase | 44,711 | 52,544 |
CMBS | ||
ASSETS | ||
Debt securities, available-for-sale | 6,480 | 6,111 |
U.S. Treasury securities | ||
ASSETS | ||
Debt securities, available-for-sale | 399,632 | 0 |
LIABILITIES | ||
Securities sold under agreements to repurchase | 397,503 | |
Residential mortgage loans | ||
ASSETS | ||
Financing receivable, after allowance for credit loss | 544,436 | 770,982 |
Residential mortgage loans in securitization trusts | ||
ASSETS | ||
Financing receivable, after allowance for credit loss | 1,028,768 | 1,027,442 |
Commercial mortgage loans | ||
ASSETS | ||
Financing receivable, after allowance for credit loss | $ 9,460 | $ 9,458 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares | Mar. 31, 2023 | Dec. 31, 2022 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (USD per share) | $ 0.01 | $ 0.01 |
Common stock authorized (shares) | 350,000,000 | 350,000,000 |
Common stock issued (shares) | 24,925,357 | 24,925,357 |
Common stock outstanding (shares) | 24,925,357 | 24,925,357 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
INTEREST INCOME, NET | ||
Interest income | $ 23,740 | $ 27,109 |
Interest expense | 16,941 | 10,170 |
NET INTEREST INCOME | 6,799 | 16,939 |
REALIZED AND UNREALIZED GAINS (LOSSES), NET | ||
Net realized gain (loss) on mortgage loans, derivative contracts, RMBS, and CMBS | (10,843) | 26,416 |
Net unrealized gain (loss) on trading securities, mortgage loans, debt at fair value option (see Note 2), and derivative contracts | 10,190 | (80,181) |
TOTAL REALIZED AND UNREALIZED GAINS (LOSSES), NET | (653) | (53,765) |
EXPENSES | ||
Operating expenses | 2,204 | 3,784 |
Operating expenses incurred with affiliate | 466 | 855 |
Due diligence and transaction costs | 0 | 770 |
Stock compensation | 541 | 871 |
Securitization costs | 883 | 2,019 |
Management fee incurred with affiliate | 1,522 | 1,873 |
Total operating expenses | 5,616 | 10,172 |
INCOME (LOSS) BEFORE INCOME TAXES | 530 | (46,998) |
Income tax benefit | 0 | (3,457) |
NET INCOME (LOSS) | 530 | (43,541) |
Preferred dividends | 0 | (4) |
NET INCOME (LOSS) ALLOCABLE TO COMMON STOCKHOLDERS | 530 | (43,545) |
Other comprehensive income (loss) | 14,804 | (12,987) |
TOTAL COMPREHENSIVE INCOME (LOSS) | $ 15,334 | $ (56,532) |
Basic earnings (loss) per common share (USD per share) | $ 0.02 | $ (1.77) |
Diluted earnings (loss) per common share (USD per share) | $ 0.02 | $ (1.77) |
Weighted average number of common shares outstanding: | ||
Basic (shares) | 24,662,737 | 24,642,961 |
Diluted (shares) | 24,925,357 | 24,642,961 |
Condensed Consolidated Statem_2
Condensed Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Thousands | Total | Preferred Stock | Common Stock at Par | Additional Paid-in Capital | Accumulated Other Comprehensive (Loss) Income | Retained Earnings (Deficit) |
Balance at beginning of period at Dec. 31, 2021 | $ 491,390 | $ 101 | $ 252 | $ 476,510 | $ 3,000 | $ 11,527 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Repurchase of common stock | (3,003) | (3,003) | ||||
Non-cash equity compensation | 871 | 871 | ||||
Dividends declared - preferred | (4) | (4) | ||||
Unrealized gain on RMBS and CMBS | (12,987) | (12,987) | ||||
Dividends paid on common stock | (11,290) | (11,290) | ||||
Net income (loss) | (43,541) | (43,541) | ||||
Balance at end of period at Mar. 31, 2022 | 421,436 | $ 101 | 252 | 474,378 | (9,987) | (43,308) |
Balance at beginning of period at Dec. 31, 2022 | 236,479 | 249 | 475,379 | (21,127) | (218,022) | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||
Non-cash equity compensation | 541 | 541 | ||||
Unrealized gain on RMBS and CMBS | 14,804 | 14,804 | ||||
Dividends paid on common stock | (7,976) | (7,976) | ||||
Net income (loss) | 530 | 530 | ||||
Balance at end of period at Mar. 31, 2023 | $ 244,378 | $ 249 | $ 475,920 | $ (6,323) | $ (225,468) |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Changes in Stockholders' Equity (Parenthetical) - $ / shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Statement of Stockholders' Equity [Abstract] | ||
Dividends paid on common stock (USD per share) | $ 0.32 | $ 0.45 |
Condensed Consolidated Statem_4
Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands | 3 Months Ended | ||
Mar. 31, 2023 | Mar. 31, 2022 | ||
CASH FLOWS FROM OPERATING ACTIVITIES | |||
Net income (loss) | $ 530 | $ (43,541) | |
Adjustments to reconcile net (loss) income to net cash used in operating activities: | |||
Net realized gain (loss) on mortgage loans, derivative contracts, RMBS, and CMBS | 10,843 | (26,416) | |
Net unrealized gain (loss) on trading securities, mortgage loans, portion of debt at fair value option, and derivative contracts | (10,190) | 80,181 | |
Accretion of discount on U.S. Treasury securities | (181) | 0 | |
Amortization of debt issuance costs | 367 | 257 | |
Net amortization of premiums and discounts on mortgage loans | 846 | 3,695 | |
Non-cash equity compensation | 541 | 871 | |
Net change in: | |||
Purchases of residential mortgage loans from non-affiliates | 0 | (330,299) | |
Purchases of residential mortgage loans from affiliates | 0 | (347,086) | |
Principal payments on residential mortgage loans in securitization trusts | 18,916 | 0 | |
Principal payments on residential mortgage loans | 18,328 | 18,239 | |
Collateral due to counterparties | 0 | 8,024 | |
Margin received from interest rate futures contracts and TBAs | 6,662 | 33,827 | |
Sale of residential mortgage loans into affiliate’s securitization trust | 229,279 | 0 | |
Principal and interest receivable on residential mortgage loans | 3,852 | (2,028) | |
Other assets | (11,477) | (2,447) | |
Management fee payable to affiliate | (448) | 12 | |
Accrued expenses | (636) | 83 | |
Accrued expenses payable to affiliate | (822) | (221) | |
Interest payable | (1,270) | 426 | |
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES | 265,140 | (606,423) | |
CASH FLOWS FROM INVESTING ACTIVITIES | |||
Purchases of investments in RMBS | (10,363) | 0 | |
Purchase of investment in U.S. Treasury securities | (399,456) | (349,992) | |
Maturity of U.S. Treasury securities | 0 | 249,999 | |
Sale of RMBS (available for sale) | 164 | 271,995 | |
Principal payments on RMBS | 101 | 3,635 | |
Principal payments on residential mortgage loans in securitization trusts | 0 | 88,228 | |
Purchases of commercial mortgage loans | 0 | (3,180) | |
Sale of commercial mortgage loans | 0 | 640 | |
Principal payments on commercial mortgage loans | 10 | 38 | |
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES | (409,544) | 261,363 | |
CASH FLOWS FROM FINANCING ACTIVITIES | |||
Dividends paid to common stockholders | (7,976) | (11,290) | |
Repurchase of common stock | 0 | (3,003) | |
Principal payments on non-recourse securitization obligation | (18,916) | (88,228) | |
Cash paid for debt issuance costs | 0 | (24) | |
Proceeds from non-recourse securitization obligations | 0 | 520,262 | |
Net proceeds from (payments on) securities sold under agreements to repurchase | 389,670 | (131,830) | |
Net proceeds from (payments on) notes payable | (200,618) | 102,757 | |
NET CASH PROVIDED BY FINANCING ACTIVITIES | 162,160 | 388,644 | |
CHANGE IN CASH AND RESTRICTED CASH | 17,756 | 43,584 | |
CASH AND RESTRICTED CASH, beginning of period | [1] | 39,861 | 52,309 |
CASH AND RESTRICTED CASH, end of period | [1] | 57,617 | 95,893 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | |||
Cash paid during the period for interest | $ 18,210 | $ 9,744 | |
[1]Cash, cash equivalents, and restricted cash as of March 31, 2023 included cash and cash equivalents of $36.8 million and restricted cash of $20.8 million, and as of March 31, 2022 included cash and cash equivalents of $90.4 million and restricted cash of $5.4 million. |
Condensed Consolidated Statem_5
Condensed Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 |
Statement of Cash Flows [Abstract] | |||
Cash and cash equivalents | $ 36,772 | $ 29,272 | $ 90,400 |
Restricted cash | $ 20,845 | $ 10,589 | $ 5,400 |
Organization and Basis of Prese
Organization and Basis of Presentation | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization and Basis of Presentation | Organization and Basis of Presentation Angel Oak Mortgage REIT, Inc. (together with its subsidiaries the “Company”), is a real estate finance company focused on acquiring and investing in first lien non-qualified residential mortgage (“non-QM”) loans and other mortgage‑related assets in the U.S. mortgage market. The Company’s strategy is to make credit-sensitive investments primarily in newly-originated first lien non‑QM loans that are primarily made to higher‑quality non‑QM loan borrowers and primarily sourced from the proprietary mortgage lending platform of affiliates, Angel Oak Mortgage Solutions LLC and Angel Oak Home Loans LLC (together, “Angel Oak Mortgage Lending”), which currently operates primarily through a wholesale channel operated by Angel Oak Mortgage Solutions, LLC and has a national origination footprint. The Company may also invest in other residential mortgage loans, residential mortgage‑backed securities (“RMBS”), and other mortgage‑related assets. The Company’s objective is to generate attractive risk‑adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The Company is a Maryland corporation incorporated on March 20, 2018. The Company achieves certain of its investment objectives by investing a portion of its assets in its wholly‑owned taxable REIT subsidiary, Angel Oak Mortgage REIT TRS, LLC (“AOMR TRS”), a Delaware limited liability company formed on March 21, 2018, which invests its assets in Angel Oak Mortgage Fund TRS, a Delaware statutory trust formed on June 15, 2018. The Company is traded on the New York Stock Exchange under the ticker symbol AOMR. The Operating Partnership On February 5, 2020, the Company formed Angel Oak Mortgage Operating Partnership, LP, a Delaware limited partnership (the “Operating Partnership”), through which substantially all of its assets are held and substantially all of its operations are conducted, either directly or through subsidiaries. The Company holds all of the limited partnership interests in the Operating Partnership and indirectly holds the sole general partnership interest in the Operating Partnership through the general partner, which is the Company’s wholly-owned subsidiary. The Company’s Manager and REIT status The Company is externally managed and advised by Falcons I, LLC (the “Manager”), a Securities and Exchange Commission-registered investment adviser and an affiliate of Angel Oak Capital Advisors, LLC (“Angel Oak Capital”). The Company has elected to be taxed as a real estate investment trust (a “REIT”) under the Internal Revenue Code of 1986, as amended, commencing with its taxable year ended December 31, 2019. Interim Financial Statements The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with the instructions to Article 10-01 of Regulation S-X for interim financial statements. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and related notes for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report on Form 10-K”). In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim periods presented. Such operating results may not be indicative of the expected results for any other interim periods or the entire year. The condensed consolidated financial statements include the accounts of the Company and its wholly‑owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Use of Estimates The preparation of financial statements requires the Company to make a number of significant estimates. These include estimates of fair value of certain assets and liabilities, amounts and timing of credit losses, prepayment rates, and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of certain revenues and expenses during the reported periods. It is likely that changes in these estimates (e.g., fair value changes due to inputs and underlying assumptions as described in Note 10 — Fair Value , credit performance, prepayments, interest rates, or other reasons) will occur in the near term. The Company’s estimates are inherently subjective in nature and actual results could differ from the Company’s estimates and the differences could be material. New Accounting Standards and Interpretations As of March 31, 2023, there were no new accounting standards or interpretations adopted by the Company that had a material effect on its condensed consolidated financial statements. Reclassifications Certain amounts reported in prior periods in the financial statements have been reclassified to conform to the current year’s presentation. For comparative purposes, and to simplify the presentation of the Company’s condensed consolidated balance sheet, the deferred tax asset has been reclassified to “other assets” on the condensed consolidated balance sheet as of December 31, 2022. See Note 14 — Other Assets . Summary of Significant Accounting Policies The Company’s summary of significant accounting policies as set forth in its Annual Report on Form 10-K remain unchanged. During the period ended March 31, 2023, the Company elected a new accounting classification regarding certain of its investments in debt securities, as further described below, as the Company classifies securities on a trade-by-trade basis upon purchase. The Company did not transfer any securities between classifications. The Company classifies its investments in debt securities in accordance with Accounting Standards Codification 320 - Investments - Debt Securities |
Variable Interest Entities
Variable Interest Entities | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Variable Interest Entities | Variable Interest Entities Since its inception, the Company has utilized Variable Interest Entities (“VIEs”) for the purpose of securitizing whole mortgage loans to obtain long-term non-recourse financing. The Company evaluates its interest in each VIE to determine if it is the primary beneficiary. Below are descriptions of VIEs for which the Company is and is not the primary beneficiary. VIEs for Which the Company is the Primary Beneficiary In 2021 and 2022, the Company entered into securitization transactions where it was determined that the Company was the primary beneficiary, as, with respect to each securitization vehicle, it controls the class of securities with call rights, or “controlling class” of securities, the XS tranche. The Company was the sole entity to contribute residential whole mortgage loans to these securitization vehicles. The retained beneficial interest in VIEs for which the Company is the primary beneficiary is the subordinated tranches of the securitization and further interests in additional interest‑only tranches. The table below sets forth the fair values of the assets and liabilities recorded in the condensed consolidated balance sheets related to these consolidated VIEs as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 Assets: (in thousands) Residential mortgage loans in securitization trusts - cost $ 1,173,764 $ 1,193,879 Fair value adjustment (144,996) (166,437) Residential mortgage loans in securitization trusts - at fair value $ 1,028,768 $ 1,027,442 Accrued interest receivable $ 1,811 $ 1,995 Liabilities (1) : Non-recourse securitization obligations, collateralized by residential mortgage loans - principal balance, amortized cost $ 462,942 $ 474,070 Less: debt issuance costs capitalized (778) (1,145) Non-recourse securitization obligations, collateralized by residential mortgage loans, amortized cost, net $ 462,164 $ 472,925 Non-recourse securitization obligations, collateralized by residential mortgage loans - principal balance, subject to fair value adjustment $ 603,325 $ 611,114 Fair value adjustment (52,785) (80,554) Non-recourse securitization obligations, collateralized by residential mortgage loans - at fair value, net $ 550,540 $ 530,560 Total non-recourse securitization obligations, collateralized by residential mortgage loans, net $ 1,012,704 $ 1,003,485 (1) Debt issuance costs for non-recourse securitization obligations electing the fair value option are recorded to expense upon issuance of the securitization. Debt issuance costs incurred with the issuances of non-recourse securitization obligations for which the fair value option was not elected are presented at amortized cost. Income and expense amounts related to the consolidated VIEs recorded in the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2023 and 2022 is set forth as follows: Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 (in thousands) Interest income $ 12,661 $ 9,508 Interest expense, non-recourse liabilities (1) (7,647) (4,583) Net interest income $ 5,014 $ 4,925 Net unrealized gain (loss) on mortgage loans in securitization trusts - at fair value 21,441 (55,174) Unrealized gain (loss) on mark-to-market of non-recourse securitization obligation - at fair value (27,768) 17,421 Securitization expenses — (2,019) Realized losses and operating expenses (757) (195) Net loss from consolidated VIEs $ (2,070) $ (35,042) (1) Interest expense includes amortization of debt issuance expense. VIEs for Which the Company is Not the Primary Beneficiary In 2019 and 2020, the Company co‑sponsored and participated along with other affiliates of Angel Oak Capital the formation of various entities that were considered to be VIEs. These VIEs were formed to facilitate securitization issuances that were comprised of secured residential whole loans and/or small balance commercial loans contributed to securitization trusts. These securities were issued as a result of the unconsolidated securitizations where the Company retained bonds from the issuances of securitizations issued by a depositor that the Company does not control. The Company determined that it was not then and is not now the primary beneficiary of any of these securitization entities, and thus has not consolidated the operating results or statements of financial position of any of these entities. The Company performs ongoing reassessments of all VIEs in which the Company has participated since its inception as to whether changes in the facts and circumstances regarding the Company’s involvement with a VIE would cause the Company’s consolidation conclusion to change, and the Company’s assessment of these VIEs remains unchanged. The securities received in the aforementioned 2019 and 2020 securitization transactions were classified as “available for sale” upon receipt and are included in “RMBS - at fair value” and “CMBS - at fair value” on the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022, and details on the accounting treatment and fair value methodology of the securities can be found in Note 10 — Fair Value Measurements . See also Note 5 — Investment Securities , for the fair value of AOMT securities held by the Company as of March 31, 2023 and December 31, 2022 that were retained by the Company as a result of these securitization transactions. |
Residential Mortgage Loans
Residential Mortgage Loans | 3 Months Ended |
Mar. 31, 2023 | |
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] | |
Residential Mortgage Loans | Residential Mortgage Loans Residential mortgage loans are mortgage loans on residences located in various states with a concentration in California and Florida. Residential mortgage loans are measured at fair value. The following table sets forth the cost, fair value, weighted average interest rate, and weighted average remaining maturity of the Company’s residential mortgage loan portfolio as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 ($ in thousands) Cost $ 620,677 $ 886,661 Unpaid principal balance $ 604,535 $ 864,171 Net premium on mortgage loans purchased 16,142 22,489 Change in fair value (76,241) (115,678) Fair value $ 544,436 $ 770,982 Weighted average interest rate 4.63 % 4.80 % Weighted average remaining maturity (years) 30 30 At times, various forms of margin maintenance may be required by certain financing facility counterparties. See Note 6 — Notes Payable . The following table sets forth data regarding the number of consumer mortgage loans secured by residential real property 90 or more days past due and also those in formal foreclosure proceedings, and the recorded investment and unpaid principal balance of such loans as of March 31, 2023 and December 31, 2022: As of: March 31, 2023 December 31, 2022 ($ in thousands) Number of mortgage loans 90 or more days past due 6 11 Recorded investment in mortgage loans 90 or more days past due $ 4,136 $ 7,230 Unpaid principal balance of loans 90 or more days past due $ 4,005 $ 7,043 Number of mortgage loans in foreclosure 3 2 Recorded investment in mortgage loans in foreclosure $ 1,512 $ 820 Unpaid principal balance of loans in foreclosure $ 1,463 $ 849 Commercial mortgage loans are mortgage loans on commercial properties located in various states with concentrations in Georgia, California, and Tennessee. Commercial mortgage loans are measured at fair value. The following table sets forth the cost, fair value, weighted average interest rate, and weighted average remaining maturity of the Company’s commercial mortgage loan portfolio as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 ($ in thousands) Cost $ 9,918 $ 9,928 Unpaid principal balance $ 9,918 $ 9,928 Change in fair value (458) (470) Fair value $ 9,460 $ 9,458 Weighted average interest rate 6.35 % 7.03 % Weighted average remaining maturity (years) 7 8 |
Commercial Mortgage Loans
Commercial Mortgage Loans | 3 Months Ended |
Mar. 31, 2023 | |
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] | |
Commercial Mortgage Loans | Residential Mortgage Loans Residential mortgage loans are mortgage loans on residences located in various states with a concentration in California and Florida. Residential mortgage loans are measured at fair value. The following table sets forth the cost, fair value, weighted average interest rate, and weighted average remaining maturity of the Company’s residential mortgage loan portfolio as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 ($ in thousands) Cost $ 620,677 $ 886,661 Unpaid principal balance $ 604,535 $ 864,171 Net premium on mortgage loans purchased 16,142 22,489 Change in fair value (76,241) (115,678) Fair value $ 544,436 $ 770,982 Weighted average interest rate 4.63 % 4.80 % Weighted average remaining maturity (years) 30 30 At times, various forms of margin maintenance may be required by certain financing facility counterparties. See Note 6 — Notes Payable . The following table sets forth data regarding the number of consumer mortgage loans secured by residential real property 90 or more days past due and also those in formal foreclosure proceedings, and the recorded investment and unpaid principal balance of such loans as of March 31, 2023 and December 31, 2022: As of: March 31, 2023 December 31, 2022 ($ in thousands) Number of mortgage loans 90 or more days past due 6 11 Recorded investment in mortgage loans 90 or more days past due $ 4,136 $ 7,230 Unpaid principal balance of loans 90 or more days past due $ 4,005 $ 7,043 Number of mortgage loans in foreclosure 3 2 Recorded investment in mortgage loans in foreclosure $ 1,512 $ 820 Unpaid principal balance of loans in foreclosure $ 1,463 $ 849 Commercial mortgage loans are mortgage loans on commercial properties located in various states with concentrations in Georgia, California, and Tennessee. Commercial mortgage loans are measured at fair value. The following table sets forth the cost, fair value, weighted average interest rate, and weighted average remaining maturity of the Company’s commercial mortgage loan portfolio as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 ($ in thousands) Cost $ 9,918 $ 9,928 Unpaid principal balance $ 9,918 $ 9,928 Change in fair value (458) (470) Fair value $ 9,460 $ 9,458 Weighted average interest rate 6.35 % 7.03 % Weighted average remaining maturity (years) 7 8 |
Investment Securities
Investment Securities | 3 Months Ended |
Mar. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Investment Securities | Investment Securities As of March 31, 2023, investment securities were comprised of non‑agency RMBS (“AOMT RMBS”), Whole Pool Agency RMBS, commercial mortgage backed securities (“CMBS”), and U.S. Treasury securities. The U.S. Treasury securities held by the Company as of March 31, 2023 subsequently matured on April 11, 2023. The Company did not hold any U.S. Treasury securities as of December 31, 2022. The following table sets forth a summary of AOMT RMBS, Whole Pool Agency RMBS, and CMBS at cost as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 (in thousands) AOMT RMBS $ 69,542 $ 69,922 Whole Pool Agency RMBS $ 447,568 $ 1,006,022 CMBS $ 6,329 $ 6,329 The following table sets forth certain information about the Company’s investments in RMBS and CMBS at fair value as of March 31, 2023 and December 31, 2022: Real Estate Securities at Fair Value Securities Sold Under Agreements to Repurchase Allocated Capital March 31, 2023: (in thousands) AOMT RMBS (1) Mezzanine $ 9,965 $ (1,372) $ 8,593 Subordinate 51,417 (28,676) 22,741 Interest Only/Excess 12,327 (1,684) 10,643 Retained RMBS in VIEs (2) — (12,979) (12,979) Total AOMT RMBS $ 73,709 $ (44,711) $ 28,998 Whole Pool Agency RMBS Fannie Mae $ 253,818 $ — $ 253,818 Freddie Mac 195,360 — 195,360 Whole Pool Total Agency RMBS $ 449,178 $ — $ 449,178 Total RMBS $ 522,887 $ (44,711) $ 478,176 AOMT CMBS Subordinate $ 2,942 $ — $ 2,942 Interest Only/Excess 3,538 — 3,538 Total AOMT CMBS $ 6,480 $ — $ 6,480 (1) AOMT RMBS held as of March 31, 2023 included both retained tranches of securitizations in which the Company participated where the Company was not deemed to be the primary beneficiary, and additional securities issued by affiliates of Angel Oak Capital which were purchased in secondary market transactions. (2) A portion of repurchase debt includes borrowings against retained bonds received from securitizations involving consolidated VIEs. These bonds have a fair value of $116.7 million. The Company reflects the underlying assets of the VIE (residential mortgage loans in securitization trusts - at fair value) on its condensed consolidated balance sheets rather than the bonds, due to the accounting rules around this type of securitization. December 31, 2022 Real Estate Securities at Fair Value Securities Sold Under Agreements to Repurchase Allocated Capital (in thousands) AOMT RMBS (1) Mezzanine $ 1,958 $ (1,470) $ 488 Subordinate 49,578 (24,982) 24,596 Interest Only/Excess 10,424 (1,506) 8,918 Retained RMBS in VIEs (2) — (24,586) (24,586) Total AOMT RMBS $ 61,960 $ (52,544) $ 9,416 Whole Pool Agency RMBS Fannie Mae $ 501,458 $ — $ 501,458 Freddie Mac 491,920 — 491,920 Whole Pool Total Agency RMBS $ 993,378 $ — $ 993,378 Total RMBS $ 1,055,338 $ (52,544) $ 1,002,794 AOMT CMBS Subordinate $ 2,901 $ — $ 2,901 Interest Only/Excess 3,210 — 3,210 Total AOMT CMBS $ 6,111 $ — $ 6,111 (1) AOMT RMBS held as of December 31, 2022 included both retained tranches of securitizations in which the Company participated where the Company was not deemed to be the primary beneficiary, and additional securities issued by affiliates of Angel Oak Capital which were purchased in secondary market transactions. (2) A portion of repurchase debt includes borrowings against retained bonds received from securitizations involving consolidated VIEs. These bonds have a fair value of $110.5 million. The Company reflects the underlying assets of the VIE (residential mortgage loans in securitization trusts - at fair value) on its condensed consolidated balance sheets rather than the bonds, due to the accounting rules around this type of securitization. The following table sets forth certain information about the Company’s investments in U.S. Treasury securities as of March 31, 2023 (1) : Date Face Value Unamortized Discount, net Amortized Cost Unrealized Loss Fair Value Net Effective Yield ($ in thousands) March 31, 2023 $ 400,000 $ 363 $ 399,637 $ (5) $ 399,632 3.55 % (1) There were no U.S. Treasury securities held as of December 31, 2022. |
Notes Payable
Notes Payable | 3 Months Ended |
Mar. 31, 2023 | |
Notes Payable [Abstract] | |
Notes Payable | Notes Payable The Company has the ability to finance residential and commercial whole loans utilizing repurchase agreements with various counterparties (“notes payable”), as further described below. Outstanding borrowings bear interest at floating rates depending on the lending counterparty, the collateral pledged, and the rate in effect for each interest period, as the same may change from time to time at the end of each interest period. Some agreements include upfront fees, fees on unused balances, covenants and concentration limits on types of collateral pledged; all vary based on the counterparty. Some of these agreements, as noted below, are “static pool” financing facilities, where the lender has agreed to finance a certain pool of loans contributed to such financing facility, which does not allow for revolving financing terms. Occasionally, a lender may require cash collateral to be posted as margin collateral on such agreements. As of March 31, 2023, cash collateral for margin maintenance requirements of approximately $15.4 million was held for the benefit of Global Investment Bank 3 within “restricted cash” on the condensed consolidated balance sheet. The majority of this restricted cash balance is in an economic interest rate hedging account under the control of Global Investment Bank 3, and may be drawn by Global Investment Bank 3 at its discretion. As of December 31, 2022, cash collateral for margin maintenance requirements by whole loan financing counterparties was $5.6 million within “restricted cash” on the condensed consolidated balance sheet, of which $3.8 million was held in a segregated restricted cash account and released to the Company by the applicable lender subsequent to December 31, 2022; the remainder of which was held in the economic interest rate hedging account referred to above. The following table sets forth the details of the Company’s notes payable and drawn amounts for whole loan purchases as of March 31, 2023 and December 31, 2022: Interest Drawn Amount Note Payable Base Interest Rate March 31, 2023 December 31, 2022 ($ in thousands) Multinational Bank 1 (1) Average Daily SOFR 2.25% $ 160,457 $ 352,038 Global Investment Bank 2 (2) 1 month SOFR 2.20% - 3.45% — — Global Investment Bank 3 (3) Compound SOFR 2.80% 278,795 119,137 Institutional Investors A and B (4) 1 month Term SOFR 3.50% N/A 168,695 Regional Bank 1 (5) 1 month SOFR 2.50% - 3.50% N/A — Total $ 439,252 $ 639,870 (1) On January 25, 2023, this financing facility was extended through July 25, 2023 in accordance with the terms of the agreement, which contemplates six-month renewals. Subsequent to March 31, 2023, the Company extended this financing facility through October 25, 2023, with an interest rate pricing spread of 2.15% (See Note 16 — Subsequent Events ). (2) This financing facility expires on February 2, 2024. (3) This static pool financing facility expires on December 19, 2023. The interest rate pricing spread per the agreement began at 2.80% for the first three months following December 19, 2022, and increases by an additional 50 basis points every three months thereafter; however, the facility does not, in general, contain “mark to market” provisions. The agreement requires an economic interest rate hedging account (“interest rate futures account”) to be maintained to the reasonable satisfaction of Global Investment Bank 3, as described above, which account is for its benefit and under its sole control. (4) On October 4, 2022, the Company and a subsidiary entered into two separate master repurchase facilities with two affiliates of an institutional investor (“Institutional Investors A and B”) regarding a specific pool of whole loans with financing of approximately $168.7 million on approximately $239.3 million of unpaid principal balance. The master repurchase agreements were set to expire on January 4, 2023, subject to a one-time option to extend for three months, which the Company did not utilize. The Company repaid this financing facility in full on January 4, 2023. The Company held restricted cash pertaining to this lender’s cash collateral requirements included in “restricted cash” on the Company’s condensed consolidated balance sheet as of December 31, 2022, as described above, which was released on January 4, 2023. (5) This agreement expired by its terms on March 16, 2023. The following table sets forth the total unused borrowing capacity of each financing line as of March 31, 2023: Note Payable Borrowing Capacity Balance Outstanding Available Financing (in thousands) Multinational Bank 1 (1) $ 600,000 $ 160,457 $ 439,543 Global Investment Bank 2 (1) 250,000 — 250,000 Global Investment Bank 3 (2) 278,795 278,795 — Total $ 1,128,795 $ 439,252 $ 689,543 (1) Although available financing is uncommitted, the Company’s unused borrowing capacity is available if it has eligible collateral to pledge and meets other borrowing conditions as set forth in the applicable agreements. (2) As of March 31, 2023, this financing facility had no unused borrowing capacity as the outstanding borrowings were based on static pools of mortgage loans. |
Due to Broker
Due to Broker | 3 Months Ended |
Mar. 31, 2023 | |
Broker-Dealer [Abstract] | |
Due to Broker | Due to Broker The “Due to broker” account on the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022, respectively, in the amounts of $447.6 million and $1.0 billion relates to the purchase of Whole Pool Agency RMBS at quarter-end in the first and fourth quarters of 2023 and 2022, respectively. Purchases are accounted for on a trade date basis, and, at times, there may be a timing difference between the trade date and the settlement date of a trade. The trade dates of these purchases were prior to the applicable quarter-end dates. These trades settled on April 13, 2023 and January 13, 2023 respectively, at which time these assets were simultaneously sold. The purchase transactions of these Whole Pool Agency RMBS are excluded from the condensed consolidated statements of cash flows as they are noncash transactions. |
Securities Sold Under Agreement
Securities Sold Under Agreements to Repurchase | 3 Months Ended |
Mar. 31, 2023 | |
Banking and Thrift, Interest [Abstract] | |
Securities Sold Under Agreements to Repurchase | Securities Sold Under Agreements to Repurchase Transactions involving securities sold under agreements to repurchase are treated as collateralized financial transactions, and are recorded at their contracted repurchase amounts. Margin (if required) for securities sold under agreements to repurchase represents margin collateral amounts held to ensure that the Company has sufficient coverage for securities sold under agreements to repurchase in case of adverse price changes. Restricted cash of margin collateral for securities sold under agreements to repurchase was $5.0 million and $3.9 million as of March 31, 2023 and December 31, 2022, respectively. The following table summarizes certain characteristics of the Company’s repurchase agreements as of March 31, 2023 and December 31, 2022: March 31, 2023 Repurchase Agreements Amount Outstanding Weighted Average Interest Rate Weighted Average Remaining Maturity (Days) ($ in thousands) U.S. Treasury securities $ 397,503 3.65 % 11 RMBS (1) $ 44,711 6.55 % 12 Total $ 442,214 3.94 % 11 December 31, 2022 Repurchase Agreements Amount Outstanding Weighted Average Interest Rate Weighted Average Remaining Maturity (Days) ($ in thousands) RMBS (1) 52,544 6.07 % 13 Total $ 52,544 6.07 % 13 (1) A portion of repurchase debt outstanding as of both March 31, 2023 and December 31, 2022 includes borrowings against retained bonds received from on-balance sheet securitizations (i.e., consolidated VIEs). See Note 5 - Investment Securities. The repurchase debt against the U.S. Treasury securities was repaid in full upon the maturity of the U.S. Treasury securities. |
Derivative Financial Instrument
Derivative Financial Instruments | 3 Months Ended |
Mar. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Financial Instruments | Derivative Financial Instruments In the normal course of business, the Company enters into derivative financial instruments to manage its exposure to market risk, including interest rate risk and prepayment risk on its whole loan investments. The derivatives in which the Company invests, and the market risk that the economic hedge is intended to mitigate are further discussed below. Derivative instruments as of March 31, 2023 and December 31, 2022 included both TBAs and interest rate futures contracts. Restricted cash relating to interest rate futures margin collateral in interest rate futures accounts under the Company’s sole control as of March 31, 2023 and December 31, 2022 included $0.4 million and $1.1 million, respectively. There was no TBA margin collateral required as of either March 31, 2023 or December 31, 2022. The Company uses interest rate futures as economic hedges to hedge a portion of its interest rate risk exposure. Interest rate risk is sensitive to many factors, including governmental monetary and tax policies, domestic and international economic and political considerations, as well as other factors. The Company’s credit risk with respect to economic hedges is the risk of default on its investments that result from a borrower’s or counterparty’s inability or unwillingness to make contractually required payments. The Company may at times hold TBAs in order to mitigate its interest rate risk on certain specified mortgage-backed securities. Amounts or obligations owed by or to the Company are subject to the right of set-off with the TBA counterparty. As part of executing these trades, the Company may enter into agreements with its TBA counterparties that govern the transactions for the TBA purchases or sales made, including margin maintenance, payment and transfer, events of default, settlements, and various other provisions. Changes in the value of derivatives designed to protect against mortgage-backed securities fair value fluctuations, or economic hedging gains and losses, are reflected in the tables below. All realized and unrealized gains and losses on derivative contracts are recognized in earnings, in “net realized gain (loss) on mortgage loans, derivative contracts, RMBS, and CMBS” for realized gains and losses, and “net unrealized gain (loss) gain on trading securities, mortgage loans, debt at fair value option, and derivative contracts” for unrealized gains and losses. The Company considers the notional amounts, categorized by primary underlying risk, to be representative of the volume of its derivative activities. The following table sets forth the derivative instruments presented on the condensed consolidated balance sheets and notional amounts as of March 31, 2023 and December 31, 2022: Notional Amounts As of: Derivatives Not Designated as Hedging Instruments Number of Contracts Assets Liabilities Long Exposure Short Exposure ($ in thousands) March 31, 2023 Interest rate futures 3,327 $ — $ (6,909) $ — $ 332,700 March 31, 2023 TBAs N/A $ — $ (1,508) $ — $ 468,800 December 31, 2022 Interest rate futures 4,928 $ 2,211 $ — $ — $ 492,800 December 31, 2022 TBAs N/A $ 12,545 $ — $ — $ 1,041,700 The gains and losses arising from these derivative instruments in the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2023 and March 31, 2022 are set forth as follows: Derivatives Not Designated as Hedging Instruments Net Realized Gains (Losses) on Derivative Instruments Net Change in Unrealized Appreciation (Depreciation) on Derivative Instruments (in thousands) Three Months Ended March 31, 2023 Interest rate futures $ 8,374 $ (9,121) Three Months Ended March 31, 2023 TBAs $ (350) $ (14,052) Three Months Ended March 31, 2022 Interest rate futures $ 19,684 $ 14,007 Three Months Ended March 31, 2022 TBAs $ 14,413 $ 1,319 |
Fair Value Measurements
Fair Value Measurements | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements For financial reporting purposes, we follow a fair value hierarchy established under GAAP that is used to determine the fair value of financial instruments. This hierarchy prioritizes relevant market inputs in order to determine an “exit price” at the measurement date, or the price at which an asset could be sold or a liability could be transferred in an orderly process that is not a forced liquidation or distressed sale. Level 1 inputs are observable inputs that reflect quoted prices for identical assets or liabilities in active markets. Level 2 inputs are observable inputs other than quoted prices for an asset or liability that are obtained through corroboration with observable market data. Level 3 inputs are unobservable inputs (e.g., our own data or assumptions) that are used when there is little, if any, relevant market activity for the asset or liability required to be measured at fair value. In certain cases, inputs used to measure fair value fall into different levels of the fair value hierarchy. In such cases, the level at which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. Our assessment of the significance of a particular input requires judgment and considers factors specific to the asset or liability being measured. As of March 31, 2023, our valuation policy and processes had not changed from those described in our consolidated financial statements for the year ended December 31, 2022 included in the Annual Report on Form 10-K. Included in Note 11 — Fair Value Measurements to the Consolidated Financial Statements for the year ended December 31, 2022 included in the Annual Report on Form 10-K is a detailed description of our other financial instruments measured at fair value and their significant inputs, as well as the general classification of such instruments pursuant to the Level 1, Level 2, and Level 3 valuation hierarchy. The fair value of cash, restricted cash, principal and interest receivable, other assets (excluding investment in majority-owned affiliate), notes payable, securities sold under agreements to repurchase, amounts due to broker and accrued expenses (including those payable to an affiliate and management fees payable to an affiliate), and interest payable approximate their carrying values due to the nature of these assets and liabilities. The Company’s “investment in majority-owned affiliate” included in other assets (see Note 14 — Other Assets ) and a portion of “non-recourse securitization obligations, collateralized by residential mortgage loans” are held at amortized cost. The fair value of these assets and liabilities is disclosed further below in the section titled “ Assets and Liabilities Held at Amortized Cost - Fair Value Disclosure ”. The following table sets forth information about the Company’s financial assets and liabilities measured at fair value as of March 31, 2023: Level 1 Level 2 Level 3 Total (in thousands) Assets, at fair value Residential mortgage loans $ — $ 539,879 $ 4,557 $ 544,436 Residential mortgage loans in securitization trusts — 1,023,085 5,683 1,028,768 Commercial mortgage loans — 9,460 — 9,460 Investments in securities Non-Agency RMBS (1) — 73,709 — 73,709 Whole Pool Agency RMBS — 449,178 — 449,178 AOMT CMBS (1) — 6,480 — 6,480 U.S Treasury Securities 399,632 — — 399,632 Total assets, at fair value $ 399,632 $ 2,101,791 $ 10,240 $ 2,511,663 Liabilities, at fair value Unrealized depreciation on futures contracts $ 6,909 $ — $ — $ 6,909 Unrealized depreciation on TBAs 1,508 — — 1,508 Non-recourse securitization obligation, collateralized by residential mortgage loans (2) — 550,540 — 550,540 Total liabilities, at fair value $ 8,417 $ 550,540 $ — $ 558,957 (1) Non‑Agency RMBS held as of March 31, 2023 included both retained tranches of securitizations in which the Company participated and additional AOMT securities purchased in secondary market transactions. All AOMT CMBS held as of March 31, 2023 were comprised of a small-balance commercial loan securitization issuance in which the Company participated. (2) Only the portion subject to fair value measurement, as adjusted for fair value, is presented above. See below for the disclosure of the full debt at fair value. Transfers from Level 2 to Level 3 were comprised of residential loans more than 90 days overdue (including those in foreclosure). Transfers between Levels are deemed to take place on the first day of the reporting period in which the transfer has taken place. These transfers were not material. We use third‑party valuation firms who utilize proprietary methodologies to value our residential and commercial loans. These firms generally use both market comparable information and discounted cash flow modeling techniques to determine the fair value of our Level 3 assets. Use of these techniques requires determination of relevant input and assumptions, some of which represent significant unobservable inputs such as anticipated credit losses, prepayment rates, default rates, or other valuation assumptions. Accordingly, a significant increase or decrease in any of these inputs in isolation may result in a significantly lower or higher fair value measurement. The following table sets forth information regarding the Company’s significant Level 3 inputs as of March 31, 2023: Input Values Asset Fair Value Unobservable Input Range Average ($ in thousands) Residential mortgage loans, at fair value $ 4,557 Prepayment rate (annual CPR) 5.82% - 27.05% 13.28% Default rate 0.10% - 3.99% 1.26% Loss severity 10.00% - 12.86% 10.51% Expected remaining life 2.16 - 6.35 years 4.78 years Residential mortgage loans in securitization trust, at fair value $ 5,683 Prepayment rate (annual CPR) 3.29% - 14.24% 8.95% Default rate 0.93% - 36.37% 16.80% Loss severity (0.08)% - 46.26% 10.25% Expected remaining life 1.42 - 4.08 years 2.46 years Assets and Liabilities Held at Amortized Cost — Fair Value Disclosure Portion of Non-Recourse Securitization Obligations, Collateralized by Residential Mortgage Loans — Held at Amortized Cost To determine the fair value of the Company’s non-recourse securitization obligations, collateralized by residential mortgage loans, net, held at amortized cost, the Company uses the same method of valuation as described in the Annual Report on Form 10-K, Note 11 — Fair Value for both the portion of the obligation measured at fair value and the portion of the obligation held at amortized cost, for which fair value is disclosed below. As of March 31, 2023, the total amortized cost basis and fair value of our non-recourse securitization obligations was $1.1 billion and $924.2 million, respectively, a difference of approximately $142.1 million (which includes AOMT 2022-1 and AOMT 2022-4, which are marked to fair value; and AOMT 2021-7, and AOMT 2021-4, which are carried at amortized cost, as the fair value option was not elected at the time of the creation of these obligations). The difference between the amortized cost and fair value solely attributable to AOMT 2021-4 and 2021-7 is approximately $89.3 million. The difference between the amortized cost basis value and the fair value is derived from the difference between the period-end market pricing of the underlying bonds, as referred to above, and the amortized cost of the obligation. The fair value of the non-recourse securitization debt is not indicative of the amounts at which we could settle this debt. As of December 31, 2022, the total amortized cost basis and fair value of our non-recourse securitization obligations was $1.1 billion and $914.3 million, respectively, a difference of approximately $170.9 million (which includes AOMT 2022-1 and AOMT 2022-4, which are marked to fair value; and AOMT 2021-7, and AOMT 2021-4, which are carried at amortized cost, as the fair value option was not elected at the time of the creation of these obligations). The difference between the amortized cost and fair value solely attributable to AOMT 2021-4 and 2021-7 is approximately $90.3 million. The difference between the amortized cost basis value and the fair value is derived from the difference between the period-end market pricing of the underlying bonds, as referred to above, and the amortized cost of the obligation. The fair value of the non-recourse securitization debt is not indicative of the amounts at which we could settle this debt. Investment in Majority-Owned Affiliate To determine the fair value of the Company’s investment in majority-owned affiliate, which is held at amortized cost and is included in “other assets”, the Company uses the prices of the underlying bonds in the investment to determine fair value. The Company utilizes PriceServe, Bank of America’s independent fixed income pricing service, as the primary valuation source for these bonds. PriceServe obtains its price quotes from actual sales or quotes for sale of the same or similar securities and/or provides model‑based valuations that consider inputs derived from recent market activity including default rates, conditional prepayment rates, loss severity, expected yield to maturity, baseline discount margin/yield, recovery assumptions, tranche type, collateral coupon, age and loan size, and other inputs specific to each security. We believe that these quotes are most reflective of the price that would be achieved if the bonds were sold to an independent third party on the date of the condensed consolidated financial statements. The amortized cost and fair value of this investment as of March 31, 2023 was approximately $11.5 million and $12.0 million, respectively. The following table sets forth information about the Company’s financial assets and liabilities measured at fair value as of December 31, 2022: Level 1 Level 2 Level 3 Total (in thousands) Assets, at fair value Residential mortgage loans $ — $ 763,786 $ 7,196 $ 770,982 Residential mortgage loans in securitization trusts — 1,018,686 8,756 1,027,442 Commercial mortgage loans — 9,458 — 9,458 Investments in securities Non-Agency RMBS (1) — 61,960 — 61,960 Whole Pool Agency RMBS — 993,378 — 993,378 AOMT CMBS (1) — 6,111 — 6,111 Unrealized appreciation on futures contracts 2,211 — — 2,211 Unrealized appreciation on TBAs 12,545 — — 12,545 Total assets, at fair value $ 14,756 $ 2,853,379 $ 15,952 $ 2,884,087 Liabilities, at fair value Non-recourse securitization obligation, collateralized by residential mortgage loans (2) $ — $ 530,560 $ — $ 530,560 Total liabilities, at fair value $ — $ 530,560 $ — $ 530,560 (1) Non‑Agency RMBS held as of December 31, 2022 included both retained tranches of AOMT securitizations in which the Company participated, additional AOMT securities purchased in secondary market transactions, and other RMBS purchased in secondary market transactions. All AOMT CMBS held as of December 31, 2022 was comprised of a small-balance commercial loan securitization issuance in which the Company participated. (2) Only the portion subject to fair value measurement, as adjusted for fair value, is presented above. Transfers from Level 2 to Level 3 were comprised of residential loans more than 90 days overdue (including those in foreclosure) and commercial mortgage loans in special servicing or otherwise considered “non‑performing” by the Company’s third‑party valuation providers. Transfers between Levels are deemed to take place on the first day of the reporting period in which the transfer has taken place. These transfers were not material. We use third‑party valuation firms who utilize proprietary methodologies to value our residential and commercial loans. These firms generally use both market comparable information and discounted cash flow modeling techniques to determine the fair value of our Level 3 assets. Use of these techniques requires determination of relevant input and assumptions, some of which represent significant unobservable inputs such as anticipated credit losses, prepayment rates, default rates, or other valuation assumptions. Accordingly, a significant increase or decrease in any of these inputs in isolation may result in a significantly lower or higher fair value measurement. The following table sets forth information regarding the Company’s significant Level 3 inputs as of December 31, 2022: Input Values Asset Fair Value Unobservable Input Range Average ($ in thousands) Residential mortgage loans, at fair value $ 7,196 Prepayment rate (annual CPR) 4.92% - 14.99% 9.39% Default rate 4.56% - 24.36% 11.43% Loss severity (0.25)% - 12.54% 7.84% Expected remaining life 0.62 - 3.43 years 2.75 years Residential mortgage loans in securitization trust, at fair value $ 8,756 Prepayment rate (annual CPR) 3.24% - 14.55% 7.84% Default rate 7.42% - 35.78% 19.07% Loss severity —% - 10.00% 9.23% Expected remaining life 1.42 - 3.72 years 2.32 years |
Related Party Transactions
Related Party Transactions | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
Related Party Transactions | Related Party Transactions Residential Mortgage Loan Purchases The Company has residential loan purchase agreements with various affiliates of the Company. The purchase price of the loans is generally equal to the outstanding principal of the mortgage, adjusted by a premium or discount, depending on market conditions. The Company purchases the mortgage loans on a servicing retained basis. The following table sets forth certain financial information pertaining to whole loan activity purchased from affiliates during the period and year ended and as of March 31, 2023 and December 31, 2022: As of and for the Year-to-Date/Year Ended: Amount of Loans Purchased from Affiliates during the Year-to-Date/Year Number of Loans Purchased from Affiliates during the Year-to-Date/Year Number of Loans Purchased from Affiliates, Owned and Held as of Year-to-Date/Year End (1) : ($ in thousands) March 31, 2023 $ — — 532 December 31, 2022 $ 567,324 1,141 845 (1) Excludes loans held in consolidated securitizations. Commercial Mortgage Loan Purchases The Company has commercial loan purchase agreements with various affiliates of the Company. The purchase price of the loans is generally equal to the outstanding principal of the mortgage, adjusted by a premium or discount, depending on market conditions. The following table sets forth certain financial information pertaining to whole loan activity purchased from affiliates during the period and year ended and as of March 31, 2023 and December 31, 2022: As of and for the Year-to-Date/Year Ended: Amount of Loans Purchased from Affiliates during the Year-to-Date/Year Number of Loans Purchased from Affiliates during the Year-to-Date/Year Number of Loans Purchased from Affiliates Held as of Year-to-Date/Year End: ($ in thousands) March 31, 2023 $ — None 4 December 31, 2022 $ — None 4 Securitization Transactions and Majority-Owned Affiliate From time to time, the Company participates in securitization transactions with other affiliates of Angel Oak Capital. See Note 2 — Variable Interest Entities , “ VIEs for Which the Company is Not the Primary Beneficiary” and Note 14 — Other Assets . Management Fee The Company’s management agreement, effective as of June 21, 2021, by and among the Company, the Operating Partnership, and the Manager (the “Management Agreement”), provides that the Company will pay the Manager, in arrears, an aggregate fixed management fee equal to 1.5% per annum of the Company’s Equity (as is defined in the Management Agreement). Incentive Fee Under the Management Agreement, the Manager is also entitled to an incentive fee, which is calculated and payable in cash with respect to each calendar quarter (or part thereof that the Management Agreement is in effect) in arrears in an amount, not less than zero, equal to the excess of (1) the product of (a) 15% and (b) the excess of (i) the Company’s Distributable Earnings (as defined in the Management Agreement) for the previous 12-month period, over (ii) the product of (A) the Company’s Equity (as defined in the Management Agreement) in the previous 12-month period, and (B) 8% per annum, over (2) the sum of any incentive fee earned by the Manager with respect to the first three calendar quarters of such previous 12-month period. To date, the incentive fee has not been earned. Operating Expense Reimbursements The Company is also required to pay the Manager reimbursements for certain general and administrative expenses pursuant to the Management Agreement. Accrued expenses payable to affiliate and operating expenses incurred with affiliate are substantially comprised of payroll reimbursements to an affiliate of the Manager. |
Commitments and Contingencies
Commitments and Contingencies | 3 Months Ended |
Mar. 31, 2023 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and ContingenciesThe Company, from time to time, may be party to litigation relating to claims arising in the normal course of business. As of March 31, 2023, the Company was not aware of any legal claims that could materially impact its financial condition. As of March 31, 2023, the Company had no unfunded commitments. |
Accumulated Other Comprehensive
Accumulated Other Comprehensive Income /(Loss) | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Accumulated Other Comprehensive Income /(Loss) | Accumulated Other Comprehensive Income/(Loss) The following table sets forth the net unrealized gain/(loss) on AFS securities for the three months ended March 31, 2023 and 2022, which is the sole component of the changes in the Company’s Accumulated Other Comprehensive Income/(Loss) (“AOCI”) for the three months ended March 31, 2023 and 2022: Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 (in thousands) AOCI balance, beginning of period $ (21,127) $ 3,000 Net unrealized gain/(loss) on AFS securities 14,804 (12,987) AOCI balance, end of period $ (6,323) $ (9,987) |
Other Assets
Other Assets | 3 Months Ended |
Mar. 31, 2023 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Other Assets | Other Assets The following table sets forth the detail of other assets included in the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 ($ in thousands) Investment in Majority-Owned Affiliate $ 11,464 $ — Deferred tax asset 3,457 3,457 Prepaid expenses 1,323 1,310 Total other assets $ 16,244 $ 4,767 Investment in Majority-Owned Affiliate (“MOA”) In the first quarter of 2023, the Company participated in a securitization transaction, AOMT 2023-1, which involved a MOA in which the Company received a 41.21% investment, proportional to its share of the unpaid principal balance of the residential whole loans contributed to the securitization. The purpose of the MOA is to retain and hold risk retention bonds issued by the securitization trust. The MOA is an LLC and is accounted for as an equity method investment and held at amortized cost. The investment will be tested for impairment at least annually utilizing undiscounted cash flows of the underlying risk retention bonds. See Note 10 — Fair Value Measurements . |
Equity and Earnings per Share (
Equity and Earnings per Share ("EPS") | 3 Months Ended |
Mar. 31, 2023 | |
Equity [Abstract] | |
Equity and Earnings per Share ("EPS") | Equity and Earnings per Share (“EPS”) In the calculations of basic and diluted earnings per common share for the three months ended March 31, 2023 and 2022, the Company included participating securities, which are certain equity awards that have non-forfeitable dividend participation rights. Dividends and undistributed earnings allocated to participating securities under the basic and diluted earnings per share calculations require specific shares to be included that may differ in certain circumstances. For the three months ended March 31, 2023, there were no anti-dilutive outstanding restricted stock awards, although the market-based “total stockholder return” conditions for 64,096 performance share units had not been achieved and thus these units were not included in the diluted weighted average common shares outstanding. For the three months ended March 31, 2022, there were 507,900 outstanding restricted stock awards that were anti-dilutive and thus not included in the diluted weighted average common shares outstanding. There were no market-based performance share units outstanding as of March 31, 2022. The following table sets forth the calculation of basic and diluted earnings per share for the three months ended March 31, 2023 and 2022: March 31, 2023 March 31, 2022 (in thousands, except share and per share data) Basic Earnings (Loss) per Common Share: Net income (loss) to common stockholders $ 530 $ (43,545) Dividends allocated to participating securities (85) — Net income (loss) to common stockholders - basic $ 445 $ (43,545) Basic weighted average common shares outstanding 24,662,737 24,642,961 Basic earnings (loss) per common share $ 0.02 $ (1.77) Diluted Earnings (Loss) per Common Share: Net income (loss) to common stockholders - basic $ 530 $ (43,545) Dividends allocated to participating securities (85) — Net income (loss) to common stockholders - diluted $ 445 $ (43,545) Basic weighted average common shares outstanding 24,662,737 24,642,961 Net effect of dilutive equity awards 262,620 — Diluted weighted average common shares outstanding 24,925,357 24,642,961 Diluted earnings (loss) per common share $ 0.02 $ (1.77) |
Subsequent Events
Subsequent Events | 3 Months Ended |
Mar. 31, 2023 | |
Subsequent Events [Abstract] | |
Subsequent Events | Subsequent Events On April 26, 2023, the Company renewed its loan financing facility with Multinational Bank 1 in accordance with the mechanism for six-month renewal periods as provided for in the original Master Repurchase Agreement with Multinational Bank 1, dated April 13, 2022. This loan financing facility has been extended to October 25, 2023, and the interest rate pricing spread decreased to 2.15%. On May 4, 2023, the Company declared a dividend of $0.32 per share of common stock, to be paid on May 31, 2023 to common stockholders of record as of May 22, 2023. |
Organization and Basis of Pre_2
Organization and Basis of Presentation (Policies) | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Basis of Presentation | The Company is a Maryland corporation incorporated on March 20, 2018. The Company achieves certain of its investment objectives by investing a portion of its assets in its wholly‑owned taxable REIT subsidiary, Angel Oak Mortgage REIT TRS, LLC (“AOMR TRS”), a Delaware limited liability company formed on March 21, 2018, which invests its assets in Angel Oak Mortgage Fund TRS, a Delaware statutory trust formed on June 15, 2018. The Company is traded on the New York Stock Exchange under the ticker symbol AOMR. The Operating Partnership On February 5, 2020, the Company formed Angel Oak Mortgage Operating Partnership, LP, a Delaware limited partnership (the “Operating Partnership”), through which substantially all of its assets are held and substantially all of its operations are conducted, either directly or through subsidiaries. The Company holds all of the limited partnership interests in the Operating Partnership and indirectly holds the sole general partnership interest in the Operating Partnership through the general partner, which is the Company’s wholly-owned subsidiary. The Company’s Manager and REIT status The Company is externally managed and advised by Falcons I, LLC (the “Manager”), a Securities and Exchange Commission-registered investment adviser and an affiliate of Angel Oak Capital Advisors, LLC (“Angel Oak Capital”). The Company has elected to be taxed as a real estate investment trust (a “REIT”) under the Internal Revenue Code of 1986, as amended, commencing with its taxable year ended December 31, 2019. |
Interim Financial Statements | Interim Financial Statements The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with the instructions to Article 10-01 of Regulation S-X for interim financial statements. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. These unaudited condensed consolidated financial statements and related notes should be read in conjunction with the consolidated financial statements and related notes for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report on Form 10-K”). In the opinion of management, the accompanying condensed consolidated financial statements contain all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim periods presented. Such operating results may not be indicative of the expected results for any other interim periods or the entire year. The condensed consolidated financial statements include the accounts of the Company and its wholly‑owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. |
Use of Estimates | Use of Estimates The preparation of financial statements requires the Company to make a number of significant estimates. These include estimates of fair value of certain assets and liabilities, amounts and timing of credit losses, prepayment rates, and other estimates that affect the reported amounts of certain assets and liabilities as of the date of the condensed consolidated financial statements and the reported amounts of certain revenues and expenses during the reported periods. It is likely that changes in these estimates (e.g., fair value changes due to inputs and underlying assumptions as described in Note 10 — Fair Value , credit performance, prepayments, interest rates, or other reasons) will occur in the near term. The Company’s estimates are inherently subjective in nature and actual results could differ from the Company’s estimates and the differences could be material. |
New Accounting Standards and Interpretations and Summary of Significant Accounting Policies | New Accounting Standards and Interpretations As of March 31, 2023, there were no new accounting standards or interpretations adopted by the Company that had a material effect on its condensed consolidated financial statements. |
VIEs for Which the Company is Not the Primary Beneficiary | VIEs for Which the Company is Not the Primary Beneficiary In 2019 and 2020, the Company co‑sponsored and participated along with other affiliates of Angel Oak Capital the formation of various entities that were considered to be VIEs. These VIEs were formed to facilitate securitization issuances that were comprised of secured residential whole loans and/or small balance commercial loans contributed to securitization trusts. These securities were issued as a result of the unconsolidated securitizations where the Company retained bonds from the issuances of securitizations issued by a depositor that the Company does not control. The Company determined that it was not then and is not now the primary beneficiary of any of these securitization entities, and thus has not consolidated the operating results or statements of financial position of any of these entities. The Company performs ongoing reassessments of all VIEs in which the Company has participated since its inception as to whether changes in the facts and circumstances regarding the Company’s involvement with a VIE would cause the Company’s consolidation conclusion to change, and the Company’s assessment of these VIEs remains unchanged. |
Reclassifications | Reclassifications Certain amounts reported in prior periods in the financial statements have been reclassified to conform to the current year’s presentation. For comparative purposes, and to simplify the presentation of the Company’s condensed consolidated balance sheet, the deferred tax asset has been reclassified to “other assets” on the condensed consolidated balance sheet as of December 31, 2022. See Note 14 — Other Assets . Summary of Significant Accounting Policies The Company’s summary of significant accounting policies as set forth in its Annual Report on Form 10-K remain unchanged. During the period ended March 31, 2023, the Company elected a new accounting classification regarding certain of its investments in debt securities, as further described below, as the Company classifies securities on a trade-by-trade basis upon purchase. The Company did not transfer any securities between classifications. The Company classifies its investments in debt securities in accordance with Accounting Standards Codification 320 - Investments - Debt Securities |
Variable Interest Entities (Tab
Variable Interest Entities (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Schedule of Variable Interest Entities | The table below sets forth the fair values of the assets and liabilities recorded in the condensed consolidated balance sheets related to these consolidated VIEs as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 Assets: (in thousands) Residential mortgage loans in securitization trusts - cost $ 1,173,764 $ 1,193,879 Fair value adjustment (144,996) (166,437) Residential mortgage loans in securitization trusts - at fair value $ 1,028,768 $ 1,027,442 Accrued interest receivable $ 1,811 $ 1,995 Liabilities (1) : Non-recourse securitization obligations, collateralized by residential mortgage loans - principal balance, amortized cost $ 462,942 $ 474,070 Less: debt issuance costs capitalized (778) (1,145) Non-recourse securitization obligations, collateralized by residential mortgage loans, amortized cost, net $ 462,164 $ 472,925 Non-recourse securitization obligations, collateralized by residential mortgage loans - principal balance, subject to fair value adjustment $ 603,325 $ 611,114 Fair value adjustment (52,785) (80,554) Non-recourse securitization obligations, collateralized by residential mortgage loans - at fair value, net $ 550,540 $ 530,560 Total non-recourse securitization obligations, collateralized by residential mortgage loans, net $ 1,012,704 $ 1,003,485 (1) Debt issuance costs for non-recourse securitization obligations electing the fair value option are recorded to expense upon issuance of the securitization. Debt issuance costs incurred with the issuances of non-recourse securitization obligations for which the fair value option was not elected are presented at amortized cost. Income and expense amounts related to the consolidated VIEs recorded in the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2023 and 2022 is set forth as follows: Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 (in thousands) Interest income $ 12,661 $ 9,508 Interest expense, non-recourse liabilities (1) (7,647) (4,583) Net interest income $ 5,014 $ 4,925 Net unrealized gain (loss) on mortgage loans in securitization trusts - at fair value 21,441 (55,174) Unrealized gain (loss) on mark-to-market of non-recourse securitization obligation - at fair value (27,768) 17,421 Securitization expenses — (2,019) Realized losses and operating expenses (757) (195) Net loss from consolidated VIEs $ (2,070) $ (35,042) (1) Interest expense includes amortization of debt issuance expense. |
Residential Mortgage Loans (Tab
Residential Mortgage Loans (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] | |
Schedule of Residential Mortgage Loans | The following table sets forth the cost, fair value, weighted average interest rate, and weighted average remaining maturity of the Company’s residential mortgage loan portfolio as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 ($ in thousands) Cost $ 620,677 $ 886,661 Unpaid principal balance $ 604,535 $ 864,171 Net premium on mortgage loans purchased 16,142 22,489 Change in fair value (76,241) (115,678) Fair value $ 544,436 $ 770,982 Weighted average interest rate 4.63 % 4.80 % Weighted average remaining maturity (years) 30 30 March 31, 2023 December 31, 2022 ($ in thousands) Cost $ 9,918 $ 9,928 Unpaid principal balance $ 9,918 $ 9,928 Change in fair value (458) (470) Fair value $ 9,460 $ 9,458 Weighted average interest rate 6.35 % 7.03 % Weighted average remaining maturity (years) 7 8 |
Schedule of Financing Receivables Past Due | The following table sets forth data regarding the number of consumer mortgage loans secured by residential real property 90 or more days past due and also those in formal foreclosure proceedings, and the recorded investment and unpaid principal balance of such loans as of March 31, 2023 and December 31, 2022: As of: March 31, 2023 December 31, 2022 ($ in thousands) Number of mortgage loans 90 or more days past due 6 11 Recorded investment in mortgage loans 90 or more days past due $ 4,136 $ 7,230 Unpaid principal balance of loans 90 or more days past due $ 4,005 $ 7,043 Number of mortgage loans in foreclosure 3 2 Recorded investment in mortgage loans in foreclosure $ 1,512 $ 820 Unpaid principal balance of loans in foreclosure $ 1,463 $ 849 |
Commercial Mortgage Loans (Tabl
Commercial Mortgage Loans (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Abstract] | |
Schedule of Commercial Mortgage Loans | The following table sets forth the cost, fair value, weighted average interest rate, and weighted average remaining maturity of the Company’s residential mortgage loan portfolio as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 ($ in thousands) Cost $ 620,677 $ 886,661 Unpaid principal balance $ 604,535 $ 864,171 Net premium on mortgage loans purchased 16,142 22,489 Change in fair value (76,241) (115,678) Fair value $ 544,436 $ 770,982 Weighted average interest rate 4.63 % 4.80 % Weighted average remaining maturity (years) 30 30 March 31, 2023 December 31, 2022 ($ in thousands) Cost $ 9,918 $ 9,928 Unpaid principal balance $ 9,918 $ 9,928 Change in fair value (458) (470) Fair value $ 9,460 $ 9,458 Weighted average interest rate 6.35 % 7.03 % Weighted average remaining maturity (years) 7 8 |
Investment Securities (Tables)
Investment Securities (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Investments, Debt and Equity Securities [Abstract] | |
Schedule of RMBS and CMBS Securities at Cost and Investments in U.S. Treasury Bills | The following table sets forth a summary of AOMT RMBS, Whole Pool Agency RMBS, and CMBS at cost as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 (in thousands) AOMT RMBS $ 69,542 $ 69,922 Whole Pool Agency RMBS $ 447,568 $ 1,006,022 CMBS $ 6,329 $ 6,329 The following table sets forth certain information about the Company’s investments in U.S. Treasury securities as of March 31, 2023 (1) : Date Face Value Unamortized Discount, net Amortized Cost Unrealized Loss Fair Value Net Effective Yield ($ in thousands) March 31, 2023 $ 400,000 $ 363 $ 399,637 $ (5) $ 399,632 3.55 % (1) There were no U.S. Treasury securities held as of December 31, 2022. |
Schedule of Investments in RMBS and CMBS at Fair Value | The following table sets forth certain information about the Company’s investments in RMBS and CMBS at fair value as of March 31, 2023 and December 31, 2022: Real Estate Securities at Fair Value Securities Sold Under Agreements to Repurchase Allocated Capital March 31, 2023: (in thousands) AOMT RMBS (1) Mezzanine $ 9,965 $ (1,372) $ 8,593 Subordinate 51,417 (28,676) 22,741 Interest Only/Excess 12,327 (1,684) 10,643 Retained RMBS in VIEs (2) — (12,979) (12,979) Total AOMT RMBS $ 73,709 $ (44,711) $ 28,998 Whole Pool Agency RMBS Fannie Mae $ 253,818 $ — $ 253,818 Freddie Mac 195,360 — 195,360 Whole Pool Total Agency RMBS $ 449,178 $ — $ 449,178 Total RMBS $ 522,887 $ (44,711) $ 478,176 AOMT CMBS Subordinate $ 2,942 $ — $ 2,942 Interest Only/Excess 3,538 — 3,538 Total AOMT CMBS $ 6,480 $ — $ 6,480 (1) AOMT RMBS held as of March 31, 2023 included both retained tranches of securitizations in which the Company participated where the Company was not deemed to be the primary beneficiary, and additional securities issued by affiliates of Angel Oak Capital which were purchased in secondary market transactions. (2) A portion of repurchase debt includes borrowings against retained bonds received from securitizations involving consolidated VIEs. These bonds have a fair value of $116.7 million. The Company reflects the underlying assets of the VIE (residential mortgage loans in securitization trusts - at fair value) on its condensed consolidated balance sheets rather than the bonds, due to the accounting rules around this type of securitization. December 31, 2022 Real Estate Securities at Fair Value Securities Sold Under Agreements to Repurchase Allocated Capital (in thousands) AOMT RMBS (1) Mezzanine $ 1,958 $ (1,470) $ 488 Subordinate 49,578 (24,982) 24,596 Interest Only/Excess 10,424 (1,506) 8,918 Retained RMBS in VIEs (2) — (24,586) (24,586) Total AOMT RMBS $ 61,960 $ (52,544) $ 9,416 Whole Pool Agency RMBS Fannie Mae $ 501,458 $ — $ 501,458 Freddie Mac 491,920 — 491,920 Whole Pool Total Agency RMBS $ 993,378 $ — $ 993,378 Total RMBS $ 1,055,338 $ (52,544) $ 1,002,794 AOMT CMBS Subordinate $ 2,901 $ — $ 2,901 Interest Only/Excess 3,210 — 3,210 Total AOMT CMBS $ 6,111 $ — $ 6,111 (1) AOMT RMBS held as of December 31, 2022 included both retained tranches of securitizations in which the Company participated where the Company was not deemed to be the primary beneficiary, and additional securities issued by affiliates of Angel Oak Capital which were purchased in secondary market transactions. (2) A portion of repurchase debt includes borrowings against retained bonds received from securitizations involving consolidated VIEs. These bonds have a fair value of $110.5 million. The Company reflects the underlying assets of the VIE (residential mortgage loans in securitization trusts - at fair value) on its condensed consolidated balance sheets rather than the bonds, due to the accounting rules around this type of securitization. |
Notes Payable (Tables)
Notes Payable (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Notes Payable [Abstract] | |
Schedule of Lines of Credit Available and Drawn Amounts for Whole Loan Purchases | The following table sets forth the details of the Company’s notes payable and drawn amounts for whole loan purchases as of March 31, 2023 and December 31, 2022: Interest Drawn Amount Note Payable Base Interest Rate March 31, 2023 December 31, 2022 ($ in thousands) Multinational Bank 1 (1) Average Daily SOFR 2.25% $ 160,457 $ 352,038 Global Investment Bank 2 (2) 1 month SOFR 2.20% - 3.45% — — Global Investment Bank 3 (3) Compound SOFR 2.80% 278,795 119,137 Institutional Investors A and B (4) 1 month Term SOFR 3.50% N/A 168,695 Regional Bank 1 (5) 1 month SOFR 2.50% - 3.50% N/A — Total $ 439,252 $ 639,870 (1) On January 25, 2023, this financing facility was extended through July 25, 2023 in accordance with the terms of the agreement, which contemplates six-month renewals. Subsequent to March 31, 2023, the Company extended this financing facility through October 25, 2023, with an interest rate pricing spread of 2.15% (See Note 16 — Subsequent Events ). (2) This financing facility expires on February 2, 2024. (3) This static pool financing facility expires on December 19, 2023. The interest rate pricing spread per the agreement began at 2.80% for the first three months following December 19, 2022, and increases by an additional 50 basis points every three months thereafter; however, the facility does not, in general, contain “mark to market” provisions. The agreement requires an economic interest rate hedging account (“interest rate futures account”) to be maintained to the reasonable satisfaction of Global Investment Bank 3, as described above, which account is for its benefit and under its sole control. (4) On October 4, 2022, the Company and a subsidiary entered into two separate master repurchase facilities with two affiliates of an institutional investor (“Institutional Investors A and B”) regarding a specific pool of whole loans with financing of approximately $168.7 million on approximately $239.3 million of unpaid principal balance. The master repurchase agreements were set to expire on January 4, 2023, subject to a one-time option to extend for three months, which the Company did not utilize. The Company repaid this financing facility in full on January 4, 2023. The Company held restricted cash pertaining to this lender’s cash collateral requirements included in “restricted cash” on the Company’s condensed consolidated balance sheet as of December 31, 2022, as described above, which was released on January 4, 2023. (5) This agreement expired by its terms on March 16, 2023. The following table sets forth the total unused borrowing capacity of each financing line as of March 31, 2023: Note Payable Borrowing Capacity Balance Outstanding Available Financing (in thousands) Multinational Bank 1 (1) $ 600,000 $ 160,457 $ 439,543 Global Investment Bank 2 (1) 250,000 — 250,000 Global Investment Bank 3 (2) 278,795 278,795 — Total $ 1,128,795 $ 439,252 $ 689,543 (1) Although available financing is uncommitted, the Company’s unused borrowing capacity is available if it has eligible collateral to pledge and meets other borrowing conditions as set forth in the applicable agreements. (2) As of March 31, 2023, this financing facility had no unused borrowing capacity as the outstanding borrowings were based on static pools of mortgage loans. |
Securities Sold Under Agreeme_2
Securities Sold Under Agreements to Repurchase (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Banking and Thrift, Interest [Abstract] | |
Schedule of Repurchase Agreements | The following table summarizes certain characteristics of the Company’s repurchase agreements as of March 31, 2023 and December 31, 2022: March 31, 2023 Repurchase Agreements Amount Outstanding Weighted Average Interest Rate Weighted Average Remaining Maturity (Days) ($ in thousands) U.S. Treasury securities $ 397,503 3.65 % 11 RMBS (1) $ 44,711 6.55 % 12 Total $ 442,214 3.94 % 11 December 31, 2022 Repurchase Agreements Amount Outstanding Weighted Average Interest Rate Weighted Average Remaining Maturity (Days) ($ in thousands) RMBS (1) 52,544 6.07 % 13 Total $ 52,544 6.07 % 13 (1) A portion of repurchase debt outstanding as of both March 31, 2023 and December 31, 2022 includes borrowings against retained bonds received from on-balance sheet securitizations (i.e., consolidated VIEs). See Note 5 - Investment Securities. |
Derivative Financial Instrume_2
Derivative Financial Instruments (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivative Instruments Presented on the Balance Sheet and Notional Amounts | The following table sets forth the derivative instruments presented on the condensed consolidated balance sheets and notional amounts as of March 31, 2023 and December 31, 2022: Notional Amounts As of: Derivatives Not Designated as Hedging Instruments Number of Contracts Assets Liabilities Long Exposure Short Exposure ($ in thousands) March 31, 2023 Interest rate futures 3,327 $ — $ (6,909) $ — $ 332,700 March 31, 2023 TBAs N/A $ — $ (1,508) $ — $ 468,800 December 31, 2022 Interest rate futures 4,928 $ 2,211 $ — $ — $ 492,800 December 31, 2022 TBAs N/A $ 12,545 $ — $ — $ 1,041,700 |
Schedule of Derivatives Not Designated as Hedging Instruments | The gains and losses arising from these derivative instruments in the condensed consolidated statements of operations and comprehensive income (loss) for the three months ended March 31, 2023 and March 31, 2022 are set forth as follows: Derivatives Not Designated as Hedging Instruments Net Realized Gains (Losses) on Derivative Instruments Net Change in Unrealized Appreciation (Depreciation) on Derivative Instruments (in thousands) Three Months Ended March 31, 2023 Interest rate futures $ 8,374 $ (9,121) Three Months Ended March 31, 2023 TBAs $ (350) $ (14,052) Three Months Ended March 31, 2022 Interest rate futures $ 19,684 $ 14,007 Three Months Ended March 31, 2022 TBAs $ 14,413 $ 1,319 |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Fair Value Disclosures [Abstract] | |
Schedule of Financial Assets and Liabilities Measured at Fair Value | The following table sets forth information about the Company’s financial assets and liabilities measured at fair value as of March 31, 2023: Level 1 Level 2 Level 3 Total (in thousands) Assets, at fair value Residential mortgage loans $ — $ 539,879 $ 4,557 $ 544,436 Residential mortgage loans in securitization trusts — 1,023,085 5,683 1,028,768 Commercial mortgage loans — 9,460 — 9,460 Investments in securities Non-Agency RMBS (1) — 73,709 — 73,709 Whole Pool Agency RMBS — 449,178 — 449,178 AOMT CMBS (1) — 6,480 — 6,480 U.S Treasury Securities 399,632 — — 399,632 Total assets, at fair value $ 399,632 $ 2,101,791 $ 10,240 $ 2,511,663 Liabilities, at fair value Unrealized depreciation on futures contracts $ 6,909 $ — $ — $ 6,909 Unrealized depreciation on TBAs 1,508 — — 1,508 Non-recourse securitization obligation, collateralized by residential mortgage loans (2) — 550,540 — 550,540 Total liabilities, at fair value $ 8,417 $ 550,540 $ — $ 558,957 (1) Non‑Agency RMBS held as of March 31, 2023 included both retained tranches of securitizations in which the Company participated and additional AOMT securities purchased in secondary market transactions. All AOMT CMBS held as of March 31, 2023 were comprised of a small-balance commercial loan securitization issuance in which the Company participated. (2) Only the portion subject to fair value measurement, as adjusted for fair value, is presented above. See below for the disclosure of the full debt at fair value. The following table sets forth information about the Company’s financial assets and liabilities measured at fair value as of December 31, 2022: Level 1 Level 2 Level 3 Total (in thousands) Assets, at fair value Residential mortgage loans $ — $ 763,786 $ 7,196 $ 770,982 Residential mortgage loans in securitization trusts — 1,018,686 8,756 1,027,442 Commercial mortgage loans — 9,458 — 9,458 Investments in securities Non-Agency RMBS (1) — 61,960 — 61,960 Whole Pool Agency RMBS — 993,378 — 993,378 AOMT CMBS (1) — 6,111 — 6,111 Unrealized appreciation on futures contracts 2,211 — — 2,211 Unrealized appreciation on TBAs 12,545 — — 12,545 Total assets, at fair value $ 14,756 $ 2,853,379 $ 15,952 $ 2,884,087 Liabilities, at fair value Non-recourse securitization obligation, collateralized by residential mortgage loans (2) $ — $ 530,560 $ — $ 530,560 Total liabilities, at fair value $ — $ 530,560 $ — $ 530,560 (1) Non‑Agency RMBS held as of December 31, 2022 included both retained tranches of AOMT securitizations in which the Company participated, additional AOMT securities purchased in secondary market transactions, and other RMBS purchased in secondary market transactions. All AOMT CMBS held as of December 31, 2022 was comprised of a small-balance commercial loan securitization issuance in which the Company participated. (2) Only the portion subject to fair value measurement, as adjusted for fair value, is presented above. |
Schedule of Significant Level 3 Inputs | The following table sets forth information regarding the Company’s significant Level 3 inputs as of March 31, 2023: Input Values Asset Fair Value Unobservable Input Range Average ($ in thousands) Residential mortgage loans, at fair value $ 4,557 Prepayment rate (annual CPR) 5.82% - 27.05% 13.28% Default rate 0.10% - 3.99% 1.26% Loss severity 10.00% - 12.86% 10.51% Expected remaining life 2.16 - 6.35 years 4.78 years Residential mortgage loans in securitization trust, at fair value $ 5,683 Prepayment rate (annual CPR) 3.29% - 14.24% 8.95% Default rate 0.93% - 36.37% 16.80% Loss severity (0.08)% - 46.26% 10.25% Expected remaining life 1.42 - 4.08 years 2.46 years The following table sets forth information regarding the Company’s significant Level 3 inputs as of December 31, 2022: Input Values Asset Fair Value Unobservable Input Range Average ($ in thousands) Residential mortgage loans, at fair value $ 7,196 Prepayment rate (annual CPR) 4.92% - 14.99% 9.39% Default rate 4.56% - 24.36% 11.43% Loss severity (0.25)% - 12.54% 7.84% Expected remaining life 0.62 - 3.43 years 2.75 years Residential mortgage loans in securitization trust, at fair value $ 8,756 Prepayment rate (annual CPR) 3.24% - 14.55% 7.84% Default rate 7.42% - 35.78% 19.07% Loss severity —% - 10.00% 9.23% Expected remaining life 1.42 - 3.72 years 2.32 years |
Related Party Transactions (Tab
Related Party Transactions (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Related Party Transactions [Abstract] | |
Schedule of Related Party Transactions | The following table sets forth certain financial information pertaining to whole loan activity purchased from affiliates during the period and year ended and as of March 31, 2023 and December 31, 2022: As of and for the Year-to-Date/Year Ended: Amount of Loans Purchased from Affiliates during the Year-to-Date/Year Number of Loans Purchased from Affiliates during the Year-to-Date/Year Number of Loans Purchased from Affiliates, Owned and Held as of Year-to-Date/Year End (1) : ($ in thousands) March 31, 2023 $ — — 532 December 31, 2022 $ 567,324 1,141 845 (1) Excludes loans held in consolidated securitizations. As of and for the Year-to-Date/Year Ended: Amount of Loans Purchased from Affiliates during the Year-to-Date/Year Number of Loans Purchased from Affiliates during the Year-to-Date/Year Number of Loans Purchased from Affiliates Held as of Year-to-Date/Year End: ($ in thousands) March 31, 2023 $ — None 4 December 31, 2022 $ — None 4 |
Accumulated Other Comprehensi_2
Accumulated Other Comprehensive Income /(Loss) (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Stockholders' Equity Note [Abstract] | |
Schedule of Accumulated Other Comprehensive Income /(Loss) | The following table sets forth the net unrealized gain/(loss) on AFS securities for the three months ended March 31, 2023 and 2022, which is the sole component of the changes in the Company’s Accumulated Other Comprehensive Income/(Loss) (“AOCI”) for the three months ended March 31, 2023 and 2022: Three Months Ended March 31, 2023 Three Months Ended March 31, 2022 (in thousands) AOCI balance, beginning of period $ (21,127) $ 3,000 Net unrealized gain/(loss) on AFS securities 14,804 (12,987) AOCI balance, end of period $ (6,323) $ (9,987) |
Other Assets (Tables)
Other Assets (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | |
Schedule of Other Assets | The following table sets forth the detail of other assets included in the condensed consolidated balance sheets as of March 31, 2023 and December 31, 2022: March 31, 2023 December 31, 2022 ($ in thousands) Investment in Majority-Owned Affiliate $ 11,464 $ — Deferred tax asset 3,457 3,457 Prepaid expenses 1,323 1,310 Total other assets $ 16,244 $ 4,767 |
Equity and Earnings per Share_2
Equity and Earnings per Share ("EPS") (Tables) | 3 Months Ended |
Mar. 31, 2023 | |
Equity [Abstract] | |
Schedule of Earnings Per Share, Basic and Diluted | The following table sets forth the calculation of basic and diluted earnings per share for the three months ended March 31, 2023 and 2022: March 31, 2023 March 31, 2022 (in thousands, except share and per share data) Basic Earnings (Loss) per Common Share: Net income (loss) to common stockholders $ 530 $ (43,545) Dividends allocated to participating securities (85) — Net income (loss) to common stockholders - basic $ 445 $ (43,545) Basic weighted average common shares outstanding 24,662,737 24,642,961 Basic earnings (loss) per common share $ 0.02 $ (1.77) Diluted Earnings (Loss) per Common Share: Net income (loss) to common stockholders - basic $ 530 $ (43,545) Dividends allocated to participating securities (85) — Net income (loss) to common stockholders - diluted $ 445 $ (43,545) Basic weighted average common shares outstanding 24,662,737 24,642,961 Net effect of dilutive equity awards 262,620 — Diluted weighted average common shares outstanding 24,925,357 24,642,961 Diluted earnings (loss) per common share $ 0.02 $ (1.77) |
Variable Interest Entities - Co
Variable Interest Entities - Consolidated Balance Sheet related to this consolidated VIE (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Residential mortgage loans in securitization trusts | ||
ASSETS | ||
Fair value | $ 1,028,768 | $ 1,027,442 |
VIE - Primary Beneficiary | ||
ASSETS | ||
Accrued interest receivable | 1,811 | 1,995 |
LIABILITIES | ||
Non-recourse securitization obligations, collateralized by residential mortgage loans - principal balance, amortized cost | 462,942 | 474,070 |
Less: debt issuance costs capitalized | (778) | (1,145) |
Non-recourse securitization obligations, collateralized by residential mortgage loans, amortized cost, net | 462,164 | 472,925 |
Non-recourse securitization obligations, collateralized by residential mortgage loans - principal balance, subject to fair value adjustment | 603,325 | 611,114 |
Fair value adjustment | (52,785) | (80,554) |
Non-recourse securitization obligations, collateralized by residential mortgage loans - at fair value, net | 550,540 | 530,560 |
Total non-recourse securitization obligations, collateralized by residential mortgage loans, net | 1,012,704 | 1,003,485 |
VIE - Primary Beneficiary | Residential mortgage loans in securitization trusts | ||
ASSETS | ||
Residential mortgage loans in securitization trusts - cost | 1,173,764 | 1,193,879 |
Fair value adjustment | (144,996) | (166,437) |
Fair value | $ 1,028,768 | $ 1,027,442 |
Variable Interest Entities - In
Variable Interest Entities - Income and expense amounts related to the consolidated VIE (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Variable Interest Entity [Line Items] | ||
Interest income | $ 23,740 | $ 27,109 |
Interest expense, non-recourse liabilities | (16,941) | (10,170) |
NET INTEREST INCOME | 6,799 | 16,939 |
VIE - Primary Beneficiary | ||
Variable Interest Entity [Line Items] | ||
Interest income | 12,661 | 9,508 |
Interest expense, non-recourse liabilities | (7,647) | (4,583) |
NET INTEREST INCOME | 5,014 | 4,925 |
Net unrealized gain (loss) on mortgage loans in securitization trusts - at fair value | 21,441 | (55,174) |
Unrealized gain (loss) on mark-to-market of non-recourse securitization obligation - at fair value | (27,768) | 17,421 |
Securitization expenses | 0 | (2,019) |
Realized losses and operating expenses | (757) | (195) |
Net loss from consolidated VIEs | $ (2,070) | $ (35,042) |
Residential Mortgage Loans - Su
Residential Mortgage Loans - Summary (Details) - Residential mortgage loans $ in Thousands | Mar. 31, 2023 USD ($) loan | Dec. 31, 2022 USD ($) loan |
Financing Receivables [Abstract] | ||
Cost | $ 620,677 | $ 886,661 |
Unpaid principal balance | 604,535 | 864,171 |
Net premium on mortgage loans purchased | 16,142 | 22,489 |
Change in fair value | (76,241) | (115,678) |
Fair value | $ 544,436 | $ 770,982 |
Weighted average interest rate | 4.63% | 4.80% |
Weighted average remaining maturity (years) | 30 years | 30 years |
Financing Receivables, Past Due [Abstract] | ||
Number of mortgage loans 90 or more days past due | loan | 6 | 11 |
Recorded investment in mortgage loans 90 or more days past due | $ 4,136 | $ 7,230 |
Unpaid principal balance of loans 90 or more days past due | $ 4,005 | $ 7,043 |
Number of mortgage loans in foreclosure | loan | 3 | 2 |
Recorded investment in mortgage loans in foreclosure | $ 1,512 | $ 820 |
Unpaid principal balance of loans in foreclosure | $ 1,463 | $ 849 |
Commercial Mortgage Loans - Sum
Commercial Mortgage Loans - Summary (Details) - Commercial mortgage loans - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Cost | $ 9,918 | $ 9,928 |
Unpaid principal balance | 9,918 | 9,928 |
Change in fair value | (458) | (470) |
Fair value | $ 9,460 | $ 9,458 |
Weighted average interest rate | 6.35% | 7.03% |
Weighted average remaining maturity (years) | 7 years | 8 years |
Commercial Mortgage Loans - Nar
Commercial Mortgage Loans - Narrative (Details) - loan | Mar. 31, 2023 | Dec. 31, 2022 |
Commercial mortgage loans | ||
SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate [Line Items] | ||
Number of mortgage loans 90 or more days past due | 0 | 0 |
Investment Securities - Securit
Investment Securities - Securities at Cost (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
AOMT RMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost of mortgage-backed securities | $ 69,542 | $ 69,922 |
Whole Pool Agency RMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost of mortgage-backed securities | 447,568 | 1,006,022 |
CMBS | ||
Debt Securities, Available-for-sale [Line Items] | ||
Cost of mortgage-backed securities | $ 6,329 | $ 6,329 |
Investment Securities - Schedul
Investment Securities - Schedule of Investments in RMBS and CMBS at Fair Value (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | $ (442,214) | $ (52,544) |
Mezzanine | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 9,965 | 1,958 |
Allocated Capital | 8,593 | 488 |
Subordinate | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 51,417 | 49,578 |
Allocated Capital | 22,741 | 24,596 |
Interest Only/Excess | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 12,327 | 10,424 |
Allocated Capital | 10,643 | 8,918 |
Retained RMBS in VIEs | VIE - Primary Beneficiary | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 0 | 0 |
Allocated Capital | (12,979) | (24,586) |
Total AOMT RMBS | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 73,709 | 61,960 |
Allocated Capital | 28,998 | 9,416 |
Fannie Mae | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 253,818 | 501,458 |
Allocated Capital | 253,818 | 501,458 |
Freddie Mac | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 195,360 | 491,920 |
Allocated Capital | 195,360 | 491,920 |
Whole Pool Total Agency RMBS | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 449,178 | 993,378 |
Allocated Capital | 449,178 | 993,378 |
RMBS | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 522,887 | 1,055,338 |
Securities Sold Under Agreements to Repurchase | (44,711) | (52,544) |
Allocated Capital | 478,176 | 1,002,794 |
Subordinate | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 2,942 | 2,901 |
Allocated Capital | 2,942 | 2,901 |
Interest Only/Excess | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 3,538 | 3,210 |
Allocated Capital | 3,538 | 3,210 |
Total AOMT CMBS | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Real Estate Securities at Fair Value | 6,480 | 6,111 |
Allocated Capital | 6,480 | 6,111 |
Mezzanine | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | (1,372) | (1,470) |
Subordinate | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | (28,676) | (24,982) |
Interest Only/Excess | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | (1,684) | (1,506) |
Retained RMBS in VIEs | VIE - Primary Beneficiary | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | (12,979) | (24,586) |
Retained RMBS in VIEs | VIE - Primary Beneficiary | Eliminations | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | 116,700 | 110,500 |
Total AOMT RMBS | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | (44,711) | (52,544) |
Fannie Mae | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | 0 | 0 |
Freddie Mac | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | 0 | 0 |
Whole Pool Total Agency RMBS | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | 0 | 0 |
RMBS | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | (44,711) | (52,544) |
Subordinate | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | 0 | 0 |
Interest Only/Excess | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | 0 | 0 |
Total AOMT CMBS | ||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Securities Sold Under Agreements to Repurchase | $ 0 | $ 0 |
Investment Securities - U.S. Tr
Investment Securities - U.S. Treasury Securities (Details) - U.S. Treasury Bills - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Dec. 31, 2022 | |
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | ||
Face Value | $ 400,000 | |
Unamortized Discount, net | 363 | |
Amortized Cost | 399,637 | |
Unrealized Loss | (5) | |
Fair Value | $ 399,632 | $ 0 |
Net Effective Yield | 3.55% |
Notes Payable - Summary (Detail
Notes Payable - Summary (Details) $ in Thousands | 3 Months Ended | |||||
Jan. 25, 2023 | Dec. 19, 2022 | Oct. 04, 2022 USD ($) facility affiliate | Mar. 31, 2023 USD ($) | Dec. 31, 2022 USD ($) | Mar. 31, 2022 USD ($) | |
Debt Instrument [Line Items] | ||||||
Restricted cash | $ 20,845 | $ 10,589 | $ 5,400 | |||
Drawn Amount | 439,252 | 639,870 | ||||
Securities sold under agreements to repurchase | $ 442,214 | 52,544 | ||||
Global Investment Bank 2 | Minimum | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest Rate Pricing Spread | 2.20% | |||||
Global Investment Bank 2 | Maximum | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest Rate Pricing Spread | 3.45% | |||||
Institutional Investors A and B | Master Repurchase Agreements | ||||||
Debt Instrument [Line Items] | ||||||
Number of master repurchase facilities | facility | 2 | |||||
Number of affiliated institutional investors | affiliate | 2 | |||||
Securities sold under agreements to repurchase | $ 168,700 | |||||
Proceeds from securitization | $ 239,300 | |||||
Notes Payable | Regional Bank 1 | Minimum | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest Rate Pricing Spread | 2.50% | |||||
Notes Payable | Regional Bank 1 | Maximum | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest Rate Pricing Spread | 3.50% | |||||
Notes Payable | Line of Credit | ||||||
Debt Instrument [Line Items] | ||||||
Drawn Amount | $ 439,252 | 639,870 | ||||
Borrowing Capacity | 1,128,795 | |||||
Available Financing | 689,543 | |||||
Notes Payable | Line of Credit | Multinational Bank 1 | ||||||
Debt Instrument [Line Items] | ||||||
Drawn Amount | 160,457 | 352,038 | ||||
Borrowing Capacity | 600,000 | |||||
Available Financing | $ 439,543 | |||||
Notes Payable | Line of Credit | Multinational Bank 1 | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest Rate Pricing Spread | 2.15% | 2.25% | ||||
Renewal period | 6 months | |||||
Notes Payable | Line of Credit | Global Investment Bank 2 | ||||||
Debt Instrument [Line Items] | ||||||
Drawn Amount | $ 0 | 0 | ||||
Borrowing Capacity | 250,000 | |||||
Available Financing | 250,000 | |||||
Notes Payable | Line of Credit | Global Investment Bank 3 | ||||||
Debt Instrument [Line Items] | ||||||
Drawn Amount | 278,795 | 119,137 | ||||
Borrowing Capacity | 278,795 | |||||
Available Financing | $ 0 | |||||
Notes Payable | Line of Credit | Global Investment Bank 3 | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest Rate Pricing Spread | 2.80% | 2.80% | ||||
Variable rate increase | 0.50% | |||||
Notes Payable | Line of Credit | Institutional Investors A and B | ||||||
Debt Instrument [Line Items] | ||||||
Drawn Amount | 168,695 | |||||
Notes Payable | Line of Credit | Institutional Investors A and B | SOFR | ||||||
Debt Instrument [Line Items] | ||||||
Interest Rate Pricing Spread | 3.50% | |||||
Notes Payable | Line of Credit | Regional Bank 1 | ||||||
Debt Instrument [Line Items] | ||||||
Drawn Amount | 0 | |||||
Collateral Pledged | ||||||
Debt Instrument [Line Items] | ||||||
Restricted cash | 5,600 | |||||
Segregated restricted cash account | $ 3,800 | |||||
Collateral Pledged | Global Investment Bank 3 | ||||||
Debt Instrument [Line Items] | ||||||
Restricted cash | $ 15,400 |
Due to Broker (Details)
Due to Broker (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Broker-Dealer [Abstract] | ||
Due to broker | $ 447,568 | $ 1,006,022 |
Securities Sold Under Agreeme_3
Securities Sold Under Agreements to Repurchase - Narrative (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Cash and Cash Equivalents | ||
Restricted Cash and Cash Equivalents Items [Line Items] | ||
Margin cash collateral | $ 5 | $ 3.9 |
Securities Sold Under Agreeme_4
Securities Sold Under Agreements to Repurchase - Summary (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 | Dec. 31, 2022 | |
Assets Sold under Agreements to Repurchase [Line Items] | ||
Amount Outstanding | $ 442,214 | $ 52,544 |
Weighted Average Interest Rate | 3.94% | 6.07% |
Weighted Average Remaining Maturity (Days) | 11 days | 13 days |
U.S. Treasury securities | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Amount Outstanding | $ 397,503 | |
Weighted Average Interest Rate | 3.65% | |
Weighted Average Remaining Maturity (Days) | 11 days | |
RMBS | ||
Assets Sold under Agreements to Repurchase [Line Items] | ||
Amount Outstanding | $ 44,711 | $ 52,544 |
Weighted Average Interest Rate | 6.55% | 6.07% |
Weighted Average Remaining Maturity (Days) | 12 days | 13 days |
Derivative Financial Instrume_3
Derivative Financial Instruments - Narrative (Details) - USD ($) | Mar. 31, 2023 | Dec. 31, 2022 | Mar. 31, 2022 |
Derivative [Line Items] | |||
Restricted cash | $ 20,845,000 | $ 10,589,000 | $ 5,400,000 |
Interest rate futures | |||
Derivative [Line Items] | |||
Restricted cash | 400,000 | 1,100,000 | |
TBAs | |||
Derivative [Line Items] | |||
Restricted cash | $ 0 | $ 0 |
Derivative Financial Instrume_4
Derivative Financial Instruments - Derivative Instruments Presented on the Balance Sheet and Notional Amounts (Details) $ in Thousands | Mar. 31, 2023 USD ($) contract | Dec. 31, 2022 USD ($) contract |
Derivative [Line Items] | ||
Assets | $ 0 | $ 14,756 |
Derivatives Not Designated as Hedging Instruments | Interest rate futures | ||
Derivative [Line Items] | ||
Number of Contracts | contract | 3,327 | 4,928 |
Assets | $ 0 | $ 2,211 |
Liabilities | (6,909) | 0 |
Derivatives Not Designated as Hedging Instruments | TBAs | ||
Derivative [Line Items] | ||
Assets | 0 | 12,545 |
Liabilities | (1,508) | 0 |
Derivatives Not Designated as Hedging Instruments | Long Exposure | Interest rate futures | ||
Derivative [Line Items] | ||
Notional Amounts | 0 | 0 |
Derivatives Not Designated as Hedging Instruments | Long Exposure | TBAs | ||
Derivative [Line Items] | ||
Notional Amounts | 0 | 0 |
Derivatives Not Designated as Hedging Instruments | Short Exposure | Interest rate futures | ||
Derivative [Line Items] | ||
Notional Amounts | 332,700 | 492,800 |
Derivatives Not Designated as Hedging Instruments | Short Exposure | TBAs | ||
Derivative [Line Items] | ||
Notional Amounts | $ 468,800 | $ 1,041,700 |
Derivative Financial Instrume_5
Derivative Financial Instruments - Gains and Losses Arising from Derivative Instruments (Details) - Derivatives Not Designated as Hedging Instruments - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Interest rate futures | ||
Derivative [Line Items] | ||
Net Realized Gains (Losses) on Derivative Instruments | $ 8,374 | $ 19,684 |
Net Change in Unrealized Appreciation (Depreciation) on Derivative Instruments | (9,121) | 14,007 |
TBAs | ||
Derivative [Line Items] | ||
Net Realized Gains (Losses) on Derivative Instruments | (350) | 14,413 |
Net Change in Unrealized Appreciation (Depreciation) on Derivative Instruments | $ (14,052) | $ 1,319 |
Fair Value Measurements - Finan
Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | $ 0 | $ 14,756 |
Total assets, at fair value | 2,511,663 | 2,884,087 |
Liabilities, at fair value | ||
Non-recourse securitization obligation, collateralized by residential mortgage loans | 550,540 | 530,560 |
Total liabilities, at fair value | 558,957 | 530,560 |
Non-Agency RMBS | ||
Assets, at fair value | ||
Fair Value | 73,709 | 61,960 |
Whole Pool Agency RMBS | ||
Assets, at fair value | ||
Fair Value | 449,178 | 993,378 |
AOMT CMBS | ||
Assets, at fair value | ||
Fair Value | 6,480 | 6,111 |
U.S. Treasury Bills | ||
Assets, at fair value | ||
Fair Value | 399,632 | 0 |
Unrealized appreciation on futures contracts | ||
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 2,211 | |
Liabilities, at fair value | ||
Unrealized depreciation | 6,909 | |
Unrealized appreciation on TBAs | ||
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 12,545 | |
Liabilities, at fair value | ||
Unrealized depreciation | 1,508 | |
Residential mortgage loans | ||
Assets, at fair value | ||
Assets, at fair value | 544,436 | 770,982 |
Residential mortgage loans in securitization trusts | ||
Assets, at fair value | ||
Assets, at fair value | 1,028,768 | 1,027,442 |
Commercial mortgage loans | ||
Assets, at fair value | ||
Assets, at fair value | 9,460 | 9,458 |
Level 1 | ||
Assets, at fair value | ||
Total assets, at fair value | 399,632 | 14,756 |
Liabilities, at fair value | ||
Non-recourse securitization obligation, collateralized by residential mortgage loans | 0 | 0 |
Total liabilities, at fair value | 8,417 | 0 |
Level 1 | Non-Agency RMBS | ||
Assets, at fair value | ||
Fair Value | 0 | 0 |
Level 1 | Whole Pool Agency RMBS | ||
Assets, at fair value | ||
Fair Value | 0 | 0 |
Level 1 | AOMT CMBS | ||
Assets, at fair value | ||
Fair Value | 0 | 0 |
Level 1 | U.S. Treasury Bills | ||
Assets, at fair value | ||
Fair Value | 399,632 | |
Level 1 | Unrealized appreciation on futures contracts | ||
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 2,211 | |
Liabilities, at fair value | ||
Unrealized depreciation | 6,909 | |
Level 1 | Unrealized appreciation on TBAs | ||
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 12,545 | |
Liabilities, at fair value | ||
Unrealized depreciation | 1,508 | |
Level 1 | Residential mortgage loans | ||
Assets, at fair value | ||
Assets, at fair value | 0 | 0 |
Level 1 | Residential mortgage loans in securitization trusts | ||
Assets, at fair value | ||
Assets, at fair value | 0 | 0 |
Level 1 | Commercial mortgage loans | ||
Assets, at fair value | ||
Assets, at fair value | 0 | 0 |
Level 2 | ||
Assets, at fair value | ||
Total assets, at fair value | 2,101,791 | 2,853,379 |
Liabilities, at fair value | ||
Non-recourse securitization obligation, collateralized by residential mortgage loans | 550,540 | 530,560 |
Total liabilities, at fair value | 550,540 | 530,560 |
Level 2 | Non-Agency RMBS | ||
Assets, at fair value | ||
Fair Value | 73,709 | 61,960 |
Level 2 | Whole Pool Agency RMBS | ||
Assets, at fair value | ||
Fair Value | 449,178 | 993,378 |
Level 2 | AOMT CMBS | ||
Assets, at fair value | ||
Fair Value | 6,480 | 6,111 |
Level 2 | U.S. Treasury Bills | ||
Assets, at fair value | ||
Fair Value | 0 | |
Level 2 | Unrealized appreciation on futures contracts | ||
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 0 | |
Liabilities, at fair value | ||
Unrealized depreciation | 0 | |
Level 2 | Unrealized appreciation on TBAs | ||
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 0 | |
Liabilities, at fair value | ||
Unrealized depreciation | 0 | |
Level 2 | Residential mortgage loans | ||
Assets, at fair value | ||
Assets, at fair value | 539,879 | 763,786 |
Level 2 | Residential mortgage loans in securitization trusts | ||
Assets, at fair value | ||
Assets, at fair value | 1,023,085 | 1,018,686 |
Level 2 | Commercial mortgage loans | ||
Assets, at fair value | ||
Assets, at fair value | 9,460 | 9,458 |
Level 3 | ||
Assets, at fair value | ||
Total assets, at fair value | 10,240 | 15,952 |
Liabilities, at fair value | ||
Non-recourse securitization obligation, collateralized by residential mortgage loans | 0 | 0 |
Total liabilities, at fair value | 0 | 0 |
Level 3 | Non-Agency RMBS | ||
Assets, at fair value | ||
Fair Value | 0 | 0 |
Level 3 | Whole Pool Agency RMBS | ||
Assets, at fair value | ||
Fair Value | 0 | 0 |
Level 3 | AOMT CMBS | ||
Assets, at fair value | ||
Fair Value | 0 | 0 |
Level 3 | U.S. Treasury Bills | ||
Assets, at fair value | ||
Fair Value | 0 | |
Level 3 | Unrealized appreciation on futures contracts | ||
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 0 | |
Liabilities, at fair value | ||
Unrealized depreciation | 0 | |
Level 3 | Unrealized appreciation on TBAs | ||
Assets, at fair value | ||
Unrealized appreciation on TBAs and interest rate futures contracts - at fair value | 0 | |
Liabilities, at fair value | ||
Unrealized depreciation | 0 | |
Level 3 | Residential mortgage loans | ||
Assets, at fair value | ||
Assets, at fair value | 4,557 | 7,196 |
Level 3 | Residential mortgage loans in securitization trusts | ||
Assets, at fair value | ||
Assets, at fair value | 5,683 | 8,756 |
Level 3 | Commercial mortgage loans | ||
Assets, at fair value | ||
Assets, at fair value | $ 0 | $ 0 |
Fair Value Measurements - Signi
Fair Value Measurements - Significant Level 3 Inputs (Details) $ in Thousands | Mar. 31, 2023 USD ($) year | Dec. 31, 2022 USD ($) year |
Residential mortgage loans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ | $ 544,436 | $ 770,982 |
Level 3 | Residential mortgage loans | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ | $ 4,557 | $ 7,196 |
Level 3 | Residential mortgage loans | Minimum | Prepayment rate (annual CPR) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.0582 | 0.0492 |
Level 3 | Residential mortgage loans | Minimum | Default rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.0010 | 0.0456 |
Level 3 | Residential mortgage loans | Minimum | Loss severity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.1000 | (0.0025) |
Level 3 | Residential mortgage loans | Minimum | Expected remaining life | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 2.16 | 0.62 |
Level 3 | Residential mortgage loans | Maximum | Prepayment rate (annual CPR) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.2705 | 0.1499 |
Level 3 | Residential mortgage loans | Maximum | Default rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.0399 | 0.2436 |
Level 3 | Residential mortgage loans | Maximum | Loss severity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.1286 | 0.1254 |
Level 3 | Residential mortgage loans | Maximum | Expected remaining life | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 6.35 | 3.43 |
Level 3 | Residential mortgage loans | Average | Prepayment rate (annual CPR) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.1328 | 0.0939 |
Level 3 | Residential mortgage loans | Average | Default rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.0126 | 0.1143 |
Level 3 | Residential mortgage loans | Average | Loss severity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.1051 | 0.0784 |
Level 3 | Residential mortgage loans | Average | Expected remaining life | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 4.78 | 2.75 |
Level 3 | Residential mortgage loans in securitization trusts | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Fair Value | $ | $ 5,683 | $ 8,756 |
Level 3 | Residential mortgage loans in securitization trusts | Minimum | Prepayment rate (annual CPR) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.0329 | 0.0324 |
Level 3 | Residential mortgage loans in securitization trusts | Minimum | Default rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.0093 | 0.0742 |
Level 3 | Residential mortgage loans in securitization trusts | Minimum | Loss severity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | (0.0008) | 0 |
Level 3 | Residential mortgage loans in securitization trusts | Minimum | Expected remaining life | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 1.42 | 1.42 |
Level 3 | Residential mortgage loans in securitization trusts | Maximum | Prepayment rate (annual CPR) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.1424 | 0.1455 |
Level 3 | Residential mortgage loans in securitization trusts | Maximum | Default rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.3637 | 0.3578 |
Level 3 | Residential mortgage loans in securitization trusts | Maximum | Loss severity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.4626 | 0.1000 |
Level 3 | Residential mortgage loans in securitization trusts | Maximum | Expected remaining life | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 4.08 | 3.72 |
Level 3 | Residential mortgage loans in securitization trusts | Average | Prepayment rate (annual CPR) | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.0895 | 0.0784 |
Level 3 | Residential mortgage loans in securitization trusts | Average | Default rate | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.1680 | 0.1907 |
Level 3 | Residential mortgage loans in securitization trusts | Average | Loss severity | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 0.1025 | 0.0923 |
Level 3 | Residential mortgage loans in securitization trusts | Average | Expected remaining life | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Loans held-for-sale, measurement input | 2.46 | 2.32 |
Fair Value Measurements - Narra
Fair Value Measurements - Narrative (Details) - USD ($) $ in Millions | Mar. 31, 2023 | Dec. 31, 2022 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Amortized cost of investment | $ 11.5 | |
Fair value of investment | 12 | |
Non-recourse | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Amortized cost of non-recourse securitization obligations | 1,100 | $ 1,100 |
Fair value of non-recourse securitization obligations | 924.2 | 914.3 |
Difference between amortized cost and fair value of non-recourse securitization obligations | 142.1 | 170.9 |
Residential mortgage loans in securitization trusts | Non-recourse | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Difference between amortized cost and fair value of non-recourse securitization obligations | $ 89.3 | $ 90.3 |
Related Party Transactions - Fi
Related Party Transactions - Financial Information on Whole Loans Purchased from Affiliates (Details) - Affiliates - Loans Purchased from Affiliates $ in Thousands | 3 Months Ended | 12 Months Ended |
Mar. 31, 2023 USD ($) loan | Dec. 31, 2022 USD ($) loan | |
Residential mortgage loans | ||
Related Party Transaction [Line Items] | ||
Amount of Loans Purchased from Affiliates during the Year-to-Date/Year | $ | $ 0 | $ 567,324 |
Number of Loans Purchased from Affiliates during the Year-to-Date/Year | 0 | 1,141 |
Number of Loans Purchased from Affiliates, Owned and Held as of Year-to-Date/Year End | 532 | 845 |
Commercial mortgage loans | ||
Related Party Transaction [Line Items] | ||
Amount of Loans Purchased from Affiliates during the Year-to-Date/Year | $ | $ 0 | $ 0 |
Number of Loans Purchased from Affiliates during the Year-to-Date/Year | 0 | 0 |
Number of Loans Purchased from Affiliates, Owned and Held as of Year-to-Date/Year End | 4 | 4 |
Related Party Transactions - Na
Related Party Transactions - Narrative (Details) - Management Agreement - Affiliates | Jun. 21, 2021 USD ($) qtr |
Related Party Transaction [Line Items] | |
Fixed management fee per annum (as a percent) | 1.50% |
Minimum incentive fee | $ | $ 0 |
Incentive fee (as a percent) | 15% |
Period for determining incentive fee by Distributed Earnings | 12 months |
Period for determining incentive fee by Equity | 12 months |
Incentive fee per annum (as a percent) | 8% |
Incentive fee, number of quarters | qtr | 3 |
Period for determining incentive fee | 12 months |
Accumulated Other Comprehensi_3
Accumulated Other Comprehensive Income /(Loss) (Details) - USD ($) $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Balance at beginning of period | $ 236,479 | $ 491,390 |
Balance at end of period | 244,378 | 421,436 |
Net unrealized gain/(loss) on AFS securities | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Balance at beginning of period | (21,127) | 3,000 |
Net unrealized gain/(loss) on AFS securities | 14,804 | (12,987) |
Balance at end of period | $ (6,323) | $ (9,987) |
Other Assets - Schedule of Othe
Other Assets - Schedule of Other Assets (Details) - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] | ||
Investment in Majority-Owned Affiliate | $ 11,464 | $ 0 |
Deferred tax asset | 3,457 | 3,457 |
Prepaid expenses | 1,323 | 1,310 |
Total other assets | $ 16,244 | $ 4,767 |
MOA | AOMT 2023-1 | ||
Noncontrolling Interest [Line Items] | ||
Investment percentage | 41.21% |
Equity and Earnings per Share_3
Equity and Earnings per Share ("EPS") - Narrative (Details) - shares | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Restricted Stock Awards | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (shares) | 0 | 507,900 |
Performance Shares | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ||
Antidilutive securities excluded from computation of earnings per share (shares) | 64,096 |
Equity and Earnings per Share_4
Equity and Earnings per Share ("EPS") - Calculation of Earnings per Share (Details) - USD ($) $ / shares in Units, $ in Thousands | 3 Months Ended | |
Mar. 31, 2023 | Mar. 31, 2022 | |
Basic Earnings (Loss) per Common Share: | ||
Net income (loss) to common stockholders - basic | $ 530 | $ (43,545) |
Dividends allocated to participating securities | (85) | 0 |
Net income (loss) to common stockholders - basic | $ 445 | $ (43,545) |
Basic weighted average common shares outstanding (shares) | 24,662,737 | 24,642,961 |
Basic earnings per common share (USD per share) | $ 0.02 | $ (1.77) |
Diluted Earnings (Loss) per Common Share: | ||
Net income (loss) to common stockholders - basic | $ 530 | $ (43,545) |
Dividends allocated to participating securities | (85) | 0 |
Net income (loss) to common stockholders - diluted | $ 445 | $ (43,545) |
Basic weighted average common shares outstanding (shares) | 24,662,737 | 24,642,961 |
Net effect of dilutive equity awards (shares) | 262,620 | 0 |
Diluted weighted average common shares outstanding (shares) | 24,925,357 | 24,642,961 |
Diluted earnings per common share (USD per share) | $ 0.02 | $ (1.77) |
Subsequent Events (Details)
Subsequent Events (Details) - $ / shares | 3 Months Ended | |||
May 04, 2023 | Apr. 26, 2023 | Jan. 25, 2023 | Mar. 31, 2023 | |
Notes Payable | Line of Credit | Multinational Bank 1 | SOFR | ||||
Subsequent Event [Line Items] | ||||
Renewal period | 6 months | |||
Interest Rate Pricing Spread | 2.15% | 2.25% | ||
Subsequent Event | ||||
Subsequent Event [Line Items] | ||||
Dividends declared per share of common stock (USD per share) | $ 0.32 | |||
Subsequent Event | Notes Payable | Line of Credit | Multinational Bank 1 | ||||
Subsequent Event [Line Items] | ||||
Renewal period | 6 months |